LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease
Open accessAbstract
SUMMARY The expression of some proteins in the autophagy pathway decline with age, which may impact neurodegeneration in diseases, including Alzheimer’s Disease. We have identified a novel non-canonical function of several autophagy proteins in the conjugation of LC3 to Rab5+, clathrin+ endosomes containing β-amyloid in a process of LC3-associated endocytosis (LANDO). We found that LANDO in microglia is a critical regulator of immune-mediated aggregate removal and microglial activation in a murine model of AD. Mice lacking LANDO but not canonical autophagy in the myeloid compartment or specifically in microglia have a robust increase in pro-inflammatory cytokine production in the hippocampus and increased levels of neurotoxic β-amyloid. This inflammation and β-amyloid deposition was associated with reactive microgliosis and tau hyperphosphorylation. LANDO-deficient AD mice displayed accelerated neurodegeneration, impaired neuronal signaling, and memory deficits. Our data support a protective role for LANDO in microglia in neurodegenerative pathologies resulting from β-amyloid deposition.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper identifies LC3-associated endocytosis (LANDO), a non-canonical autophagy-protein-dependent process in microglia that conjugates LC3 to Rab5+/clathrin+ endosomes containing β-amyloid and supports recycling of Aβ receptors. Loss of LANDO, but not canonical autophagy, exacerbates Aβ deposition, neuroinflammation, tau pathology, neurodegeneration, and memory deficits in 5xFAD mice.
Key findings
- LANDO requires ATG5 and Rubicon, but not FIP200, for LC3 recruitment to Aβ-containing endosomes; ATG5- or Rubicon-deficient BV2 microglia showed reduced LC3 recruitment and membrane-associated LC3, while FIP200 deficiency did not.
- In 4-month-old 5xFAD mice, myeloid ATG5 deficiency and global or microglia-specific Rubicon deficiency increased hippocampal and cortical Aβ plaque number/size, pro-inflammatory cytokines (TNFα, IL-1β, IL-6), reactive microgliosis, and tau hyperphosphorylation; myeloid or microglial FIP200 deficiency had no effect.
- LANDO-deficient cells showed impaired secondary Aβ uptake and abrogated recycling of CD36, TLR4, and TREM2, while primary Aβ uptake, Aβ degradation, endosome maturation, and lysosome association were unaffected.
- LANDO-deficient 5xFAD mice displayed accelerated neurodegeneration: reduced NeuN+ hippocampal neurons, increased cleaved-caspase 3 in CA3, impaired hippocampal synaptic transmission and LTP, and behavioral/memory deficits; Rubicon-deficient mice showed anhedonia as young as 2.5 months and approximately 50% sucrose preference by 4 months.
Methods
- Murine AD model: 5xFAD mice crossed with myeloid LysM-Cre conditional FIP200 or ATG5, germline Rubicon−/−, or CX3CR1-creERT2 conditional Rubicon/FIP200; experiments used mixed-sex cohorts at 4 months unless noted, on >97% C57BL/6J background.
- Cell and biochemical assays: BV2 microglia, RAW264.7 macrophages, primary BMDMs and microglia; CRISPR/Cas9 knockouts, GFP-LC3, oligomeric Aβ1-42, microscopy, flow cytometry, immunoblot, qPCR, ELISA, pH-rodo maturation, receptor recycling, Aβ uptake, electrophysiology, and behavior (sucrose preference, Y-maze, novel object recognition).
- Statistics: GraphPad Prism 7.0, powered to at least 0.8 by G*Power, significance at p < 0.05.
Limitations
- Stated: the 5xFAD models cannot fully exclude a role for infiltrating peripheral monocytes in Aβ clearance and neuroinflammation; CX3CR1-creERT2 transient ablation may not completely exclude Rubicon-deficient peripheral monocytes entering the brain before reconstitution.
- Stated: the receptor-recycling assay does not evaluate LANDO’s role in receptor degradation or other endosome-trafficking perturbations, and altered receptor signaling could promote cytokine expression; the authors also cannot formally exclude LAP functions in Aβ clearance/response in vivo.
- Evident from the text: findings are based on murine 5xFAD models and cultured cell systems, with no human validation reported; the authors also note tamoxifen may reduce Aβ oligomerization as a possible confound in MG-cre animals.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 59 cited sources checked · 0 supported · 0 flagged
- Findingown data
Primary microglia isolated from LysM-Cre+ FIP200fl/fl and ATG5fl/fl mice show a significant reduction in mRNA and protein expression compared to LysM-Cre− littermates.
“Primary microglia isolated from LysM-Cre+ FIP200fl/fl and ATG5fl/fl mice (referred to as FIP200,cre+ and ATG5,cre+) showed a significant reduction in mRNA and protein expression when compared to LysM-Cre− littermates (Fig. S1A,B).”
Quote in the paperSubstantial claim - Findingown data
The autophagy protein FIP200 does not have the protective function against Aβ accumulation, neuroinflammation, and neurodegeneration that ATG5 has.
“In contrast, another requisite autophagy protein, RB1-inducible coiled-coil protein 1, also called FIP200 (herein, FIP200), has no such function.”
Quote in the paperSubstantial claim - Findingown data
In the myeloid compartment (including microglia), the autophagy protein ATG5 promotes protection from Aβ accumulation, neuroinflammation, and neurodegeneration.
“We employed an established murine model of AD and found that in the myeloid compartment (including microglia), the autophagy protein, ATG5, promoted protection from Aβ accumulation, neuroinflammation, and neurodegeneration.”
Quote in the paperSubstantial claim - Findingown data
LANDO is a novel form of receptor-mediated endocytosis and receptor recycling characterized by association of LC3/GABARAP-family proteins with endosomal membranes.
“In dissecting these effects, we identified a novel form of RME and receptor recycling characterized by association of LC3/GABARAP-family proteins (herein, “LC3”) with endosomal membranes, a process we call LC3-Associated eNDOcytosis (LANDO).”
Quote in the paperSubstantial claim - Findingown data
Rubicon, a protein that constrains canonical autophagy, is required for the protective effects against Aβ accumulation, neuroinflammation, and neurodegeneration.
“Strikingly, a protein that constrains canonical autophagy, Rubicon, was similarly required for the protective effects.”
Quote in the paperSubstantial claim
- Findingown data
LysM-cre does not cause changes in endogenous FIP200 or ATG5 protein expression in primary neurons.
“Therefore, we analyzed FIP200 and ATG5 protein expression in primary neurons from both FIP200 and ATG5 genotypes using LysM-cre and observed no changes in endogenous expression levels (Fig. S1C).”
Quote in the paperSubstantial claim - Findingown data
Rubicon−/− primary microglia show potent hyperactivation of TNFα, IL1-β, and IL-6 at both mRNA and protein levels upon Aβ1-42 exposure.
“A potent hyperactivation of TNFα, IL1-β and IL-6 was observed at both the mRNA (Fig. 3E) and protein levels (Fig. 3F) upon Aβ1-42 exposure in Rubicon−/− microglia.”
Quote in the paperSubstantial claim - Findingown data
Rubicon deficiency dramatically reduces TREM2 recycling in primary microglia.
“Rubicon-deficiency dramatically reduced recycling of TREM2 (Fig. 2J,K).”
Quote in the paperSubstantial claim - Findingown data
In 5xFAD Rubicon-deficient mice, analysis of microglia-plaque association revealed an increase in plaque-associated microglia.
“Furthermore, in 5xFAD Rubicon-deficient mice, analysis of microglia-plaque association revealed an increase in plaque-associated microglia (Fig. 4F), suggestive of progressive gliosis in response to Aβ.”
Quote in the paperNot a substantial claim - Findingown data
Genotypes that displayed defective receptor recycling showed a dramatically elevated TNFα, IL-1β, and IL-6 response to Aβ1-42 in BMDMs.
“Strikingly, those genotypes that displayed defective receptor recycling showed a dramatically elevated TNFα, IL-1β, and IL-6 response to Aβ1-42 (Fig. 3C).”
Quote in the paperSubstantial claim - Findingown data
LC3+ Aβ-containing vesicles co-localize with clathrin and the endosomal marker Rab5.
“Consistent with this hypothesis, LC3+ Aβ-containing vesicles showed co-localization of clathrin and the endosomal marker Rab5 with LC3 (Fig. S2B).”
Quote in the paperSubstantial claim - Findingown data
5xFAD Rubicon−/− and myeloid ATG5-deficient mice did not have a decrease in total arm entries in the Y-maze test.
“Consistent with their performance in the SPT, 5xFAD Rubicon−/− and myeloid ATG5-deficient mice had a reduction in spontaneous alternation (Fig. 7C) without having a decrease in total arm entries (Fig. 7D) in the Y-maze test.”
Quote in the paperNot a substantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Findingown data
Both global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 in 5xFAD mice resulted in tau hyperphosphorylation.
“We observed that both global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 resulted in exacerbated Aβ deposition and plaque formation, reactive microgliosis, tau hyperphosphorylation, and neuronal cell death and dysfunction, leading to significant memory impairment.”
Quote in the paperSubstantial claim- Rests on an assumption: The 5xFAD mouse model is a well-characterized model of Aβ aggregate deposition and Alzheimer's disease.
- Findingown data
5xFAD mice deficient in myeloid FIP200 showed no variation in sucrose preference compared to wild-type 5xFAD animals.
“5xFAD mice deficient in myeloid FIP200 showed no variation in their preference for sucrose water when compared to wild-type 5xFAD animals, suggesting they have intact reward behavior (Fig. 7A).”
Quote in the paperNot a substantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Findingown data
5xFAD Rubicon-deficient mice presented with anhedonia as young as 2.5 months old.
“5xFAD, Rubicon-deficient mice presented with anhedonia as young as 2.5 months old.”
Quote in the paperSubstantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Findingown data
5xFAD Rubicon−/− and myeloid ATG5-deficient mice had a reduction in spontaneous alternation in the Y-maze test.
“Consistent with their performance in the SPT, 5xFAD Rubicon−/− and myeloid ATG5-deficient mice had a reduction in spontaneous alternation (Fig. 7C) without having a decrease in total arm entries (Fig. 7D) in the Y-maze test.”
Quote in the paperSubstantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Findingown data
Rubicon-deficiency resulted in a decrease in novel object preference in 5xFAD mice.
“Rubicon-deficiency resulted in a decrease in novel object preference, and an almost complete reduction in their discrimination index (Fig 7F,G).”
Quote in the paperSubstantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Findingown data
LANDO is required for the recycling of putative Aβ receptors (CD36, TREM2, and TLR4) from internalized endosomes to the plasma membrane.
“According to the receptor-recycling method we employed and established by others (Lucin et al., 2013; Yin et al., 2016), we found that LANDO is required for the recycling of putative Aβ receptors (CD36, TREM2, and TLR4) from internalized endosomes to the plasma membrane.”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
5xFAD Rubicon-deficient mice show a robust increase in cleaved-caspase 3-positive neurons in the CA3 field of the hippocampus compared to littermate controls.
“There was a robust increase in cleaved-caspase 3-positive neurons in 5xFAD Rubicon-deficient mice compared to littermate controls in the CA3-field of the hippocampus (Fig. 6C,D).”
Quote in the paperSubstantial claim - Findingown data
Rubicon-deficiency resulted in an almost complete reduction in discrimination index in 5xFAD mice.
“Rubicon-deficiency resulted in a decrease in novel object preference, and an almost complete reduction in their discrimination index (Fig 7F,G).”
Quote in the paperSubstantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Findingown data
Short-to-medium term memory was drastically reduced in 5xFAD Rubicon−/− mice, as measured by NOR.
“Moreover, short-to-medium term memory was drastically reduced in the 5XFAD Rubicon−/− mice, as measured by NOR.”
Quote in the paperSubstantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Findingown data
Both Rubicon- and myeloid ATG5-deficient 5xFAD mice presented with anhedonia, at approximately 50% sucrose preference by 4 months of age.
“In contrast, both Rubicon and myeloid ATG5-deficient mice presented with anhedonia.”
- Also stated in: § LANDO-deficiency accelerates behavioral and memory impairment in 5xFAD mice · plain
“Both genotypes were at approximately 50% sucrose preference, or simple chance (Fig. 7A) by 4 months of age.”
Quote in the paperSubstantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Also stated in: § LANDO-deficiency accelerates behavioral and memory impairment in 5xFAD mice · plain
- Findingown data
Myeloid or microglial deficiency in FIP200 failed to have an effect on the above parameters when compared to littermate controls.
“Myeloid or microglial deficiency in FIP200 failed to have an effect on the above parameters when compared to littermate controls.”
Quote in the paperSubstantial claim- Rests on an assumption: The 5xFAD mouse model is a well-characterized model of Aβ aggregate deposition and Alzheimer's disease.
- Findingown data
The reactive microgliosis observed in 5xFAD Rubicon and myeloid ATG5-deficient mice resulted in robust increases in neuroinflammatory activation.
“The reactive microgliosis we observed in the 5xFAD Rubicon and myeloid ATG5-deficient mice resulted in robust increases in neuroinflammatory activation.”
Quote in the paperSubstantial claim - Findingown data
Rubicon, ATG5, ATG7, and ATG4 were required for receptor recycling.
“We further found that Rubicon, ATG5, ATG7, and ATG4 were required, while ULK1, FIP200, and ATG14 were dispensable for this effect.”
Quote in the paperSubstantial claim - Findingcitation
RavZ prevented receptor recycling.
“The Legionella-derived protease, RavZ, which irreversibly cleaves lipidated LC3 (Choy et al., 2012; Kwon et al., 2017) also prevented this receptor recycling, again, as defined by this method (Lucin et al., 2013; Yin et al., 2016).”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingown data
A subset of autophagy proteins including Beclin1, ATG5, and ATG7 are obligatory for LANDO function.
“We have found that a subset of the autophagy proteins including Beclin1, ATG5, and ATG7 are obligatory for LANDO function.”
Quote in the paperSubstantial claim - Findingown data
The paper confirmed in primary BMDM that recycling of CD36 and TREM2 is dependent on Beclin1 and VPS34.
“A previous study had shown that this recycling of CD36 and TREM2 is dependent on Beclin1 and VPS34 (Lucin et al., 2013), which we confirmed in primary BMDM (Fig. 3).”
Quote in the paperNot a substantial claim - Findingown data
LANDO-deficient cells did not display increased persistence of endosomal Aβ.
“We had previously suggested that persistence of cargo in LAP-deficient cells enables continued signaling at the phagosome membrane, however LANDO-deficient cells did not display increased persistence of endosomal Aβ.”
Quote in the paperSubstantial claim - Findingown data
No increase in peripheral macrophage infiltration was found at 4 months of age in 5xFAD Rubicon-deficient mice.
“We found, however, no increase in peripheral macrophage infiltration at 4-months of age in our 5xFAD Rubicon-deficient mice (Figure S5).”
Quote in the paperSubstantial claim - Premisecitation
The 5xFAD mouse model expresses transgenes of APP and Presenilin1 containing several mutations associated with human familial Alzheimer's disease.
“we employed a murine model in which animals express transgenes of APP and Presenilin1 containing several mutations associated with human familial AD, the 5xFAD (B6.Cg-Tg (APPSwFILon, PSEN1 *M146L*L286V) 6799Vas) model (Oakley et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Oakley et al., 2006 source
Not checked in the free run.
- Interpretationreasoning
Changes in the expression of autophagy proteins can influence Alzheimer's disease pathology in a manner that does not involve canonical autophagy.
“This alternative function of some components of the autophagy pathway support the idea that changes in the expression of autophagy proteins can influence AD pathology in a manner that does not involve canonical autophagy.”
Quote in the paperSubstantial claim - Interpretationown data
These results argue against a role for LAP in regulating Aβ endocytosis and degradation.
“These results argue against a role for LAP in regulating Aβ endocytosis and degradation.”
Quote in the paperSubstantial claim - Interpretationown data
Rubicon and myeloid ATG5 play a critical role in mitigating reactive/inflammatory microglial activation in the 5xFAD model.
“These results suggest a critical role for Rubicon and myeloid ATG5 in mitigating reactive/inflammatory microglial activation in the 5xFAD model.”
Quote in the paperSubstantial claim - Interpretationown data
The increase in plaque-associated microglia in 5xFAD Rubicon-deficient mice is suggestive of progressive gliosis in response to Aβ.
“Furthermore, in 5xFAD Rubicon-deficient mice, analysis of microglia-plaque association revealed an increase in plaque-associated microglia (Fig. 4F), suggestive of progressive gliosis in response to Aβ.”
Quote in the paperNot a substantial claim - Interpretationown data
Lipidation of LC3-family proteins is required for recycling of TLR4, TREM2, and CD36.
“The requirement for ATG4, which converts LC3 to LC3-I (Kabeya et al., 2004) and the effect of RavZ, which irreversibly cleaves lipidated LC3 (Choy et al., 2012; Kwon et al., 2017), strongly suggest that lipidation of LC3-family proteins is required for recycling of these receptors.”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
The exacerbation of Aβ accumulation in myeloid ATG5- and Rubicon-deficient mice but not in FIP200-deficient mice suggests an alternative function of canonical autophagy proteins in the regulation of Aβ deposition.
“The exacerbation of Aβ accumulation within the hippocampus and cortex of the myeloid ATG5 and Rubicon-deficient mice but not in mice deficient in myeloid FIP200 is suggestive of an alternative function of canonical autophagy proteins in the regulation of Aβ deposition.”
Quote in the paperSubstantial claim - Interpretationreasoning
LANDO plays a more central role than LAP in the clearance and response to Aβ in vivo.
“While we cannot formally exclude functions for LAP in the clearance and response to Aβ in vivo, our results strongly suggest that LANDO plays a more central role in this process.”
Quote in the paperSubstantial claim - Interpretationown data
LANDO mitigates inflammatory activation in response to Aβ.
“Together, these results suggest a role for LANDO in the mitigation of inflammatory activation in response to Aβ.”
Quote in the paperSubstantial claim - Interpretationreasoning
The exacerbation of Aβ accumulation in LANDO-deficient mice is a result of impaired recycling of putative Aβ receptors leading to extracellular deposition.
“Our data suggest that the exacerbation of Aβ accumulation in our LANDO-deficient mice is a result of impaired recycling of putative Aβ receptors leading to extracellular deposition.”
Quote in the paperSubstantial claim - Premisecitation
Aβ, especially the Aβ1-42 oligomer and fibril, is an established instigator of neuroinflammation.
“Aβ, especially the Aβ1-42 oligomer and fibril, is an established instigator of neuroinflammation (Cai et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cai et al., 2014 source
Not checked in the free run.
- Interpretationown data
5xFAD mice deficient in myeloid FIP200 have intact reward behavior.
“5xFAD mice deficient in myeloid FIP200 showed no variation in their preference for sucrose water when compared to wild-type 5xFAD animals, suggesting they have intact reward behavior (Fig. 7A).”
Quote in the paperNot a substantial claim- Rests on an assumption: The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
- Premisecitation
Behavioral and memory deficits do not typically begin to show significant differences in 5xFAD animals until at least 5-7 months of age.
“Interestingly, behavioral and memory deficits do not typically begin to show significant differences in 5xFAD animals until at least 5-7 months of age (Girard et al., 2014; Ohno, 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
When microglial LANDO is defective, Aβ-induced neuronal cell death is accelerated, particularly in pre-synaptic neurons of the hippocampus.
“Therefore, when microglial LANDO is defective, neuronal cell death induced by Aβ is accelerated, particularly within the pre-synaptic neurons of the hippocampus.”
Quote in the paperSubstantial claim - Interpretationown data
Reduction of the pre-synaptic neuronal population was confirmed by inhibition of pre-synaptic transmission and LTP.
“Reduction of this neuronal population was confirmed by inhibition of pre-synaptic transmission and LTP.”
Quote in the paperSubstantial claim - Interpretationown data
Loss of LANDO promotes rapid alterations to tau that are indicative of highly progressive disease.
“These data suggest loss of LANDO promotes rapid alterations to tau that are indicative of highly progressive disease.”
Quote in the paperSubstantial claim - Interpretationown data
Results from the SPT suggested a pervasive memory impairment.
“Results from the SPT suggested a pervasive memory impairment.”
Quote in the paperSubstantial claim - Interpretationreasoning
The observed roles for ATG5 and Rubicon, but not FIP200, are reminiscent of LAP.
“The observed roles for ATG5 and Rubicon, but not FIP200, is reminiscent of LAP.”
Quote in the paperNot a substantial claim - Interpretationown data
Control of Aβ deposition and microglial activation by LANDO is critical for preventing hyperphosphorylation of tau, neuronal apoptosis, and degeneration.
“In combination, these results support the idea that control of Aβ deposition and microglial activation by LANDO is critical for preventing hyperphosphorylation of tau, neuronal apoptosis, and degeneration.”
Quote in the paperSubstantial claim - Interpretationown data
The results suggest LANDO is required in microglia for imparting the protection observed in the 5xFAD models.
“Therefore, although our results suggest LANDO is required in microglia for imparting the protection observed in our 5xFAD models, we cannot completely exclude any involvement of peripheral immune cells in the effects we observed.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The paper cannot completely exclude any involvement of peripheral immune cells in the effects observed.
“Therefore, although our results suggest LANDO is required in microglia for imparting the protection observed in our 5xFAD models, we cannot completely exclude any involvement of peripheral immune cells in the effects we observed.”
Quote in the paperNot a substantial claim - Premisecitation
A previous study using parabiosis demonstrated a negligible contribution of circulating monocytes to the microglial pool in 5xFAD mice.
“A previous study utilized parabiosis to evaluate the contribution of circulating monocytes to the microglial pool in 5xFAD mice and demonstrated a negligible contribution of peripheral cells (Wang et al., 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wang et al., 2016 source
Not checked in the free run.
- Interpretationown data
The paper's findings support that LANDO in the myeloid compartment of the CNS, and more specifically in microglia, functions to protect neurons from the neuroinflammatory and neurodegenerative effects of Aβ deposition.
“Nevertheless, our findings support the notion that LANDO in the myeloid compartment of the CNS and more specifically in microglia, functions to protect neurons from the neuroinflammatory and neurodegenerative effects of Aβ deposition.”
Quote in the paperSubstantial claim - Premisecitation
Expression of Beclin1, ATG5, and ATG7 decreases with age.
“The expression of these three proteins decreases with age (Lipinski et al., 2010), which may lead to an insufficiency in LANDO, establishing a putative risk factor for pathology.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lipinski et al., 2010 source
Not checked in the free run.
- Interpretationown data
Microglial Rubicon and myeloid ATG5 are protective against Aβ-induced pro-inflammatory cytokine production and its consequences.
“Our data strongly suggest that microglial Rubicon and myeloid ATG5 are protective against Aβ-induced pro-inflammatory cytokine production and its consequences (Fig. 3 and 4).”
Quote in the paperSubstantial claim - Study design and conductreasoning
One caveat to the 5xFAD models used is the inability to fully exclude a role for infiltrating peripheral monocytes in Aβ clearance and neuroinflammation.
“One caveat to the 5xFAD models used herein is the inability to fully exclude a role for infiltrating peripheral monocytes in Aβ clearance and neuroinflammation.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Effects in microglia of the CNS are more likely due to LANDO.
“While autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), effects in microglia of the CNS are more likely due to LANDO.”
Quote in the paperNot a substantial claim
- May combine two claims. 48
- Classified as probably not a substantial claim. 26
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataIn 5xFAD mice, absence of Rubicon (global or microglial) or myeloid ATG5 leads to accelerated disease pathology, neurodegeneration, reactive microgliosis, tau pathology, and behavioral impairment, whereas FIP200 deficiency does not.
“In the absence of Rubicon either globally or conditionally in microglia, or myeloid ATG5 (but not myeloid or microglial FIP200), we observed accelerated disease pathology and neurodegeneration, reactive microgliosis, tau pathology, and behavioral impairment.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn 5xFAD mice, autophagy deficiency (FIP200 LysM- or MG-cre+) does not alter Aβ deposition, whereas myeloid ATG5 deficiency and Rubicon deficiency (global or microglial) increase Aβ plaque number and size in the hippocampus and cortex.
“Consistent with this notion and similar to mice deficient in myeloid ATG5, 5xFAD Rubicon−/− mice and 5xFAD Rubicon MG-cre+ mice displayed an increase in Aβ plaque number and plaque size compared to either Rubicon+/− or MG-cre− littermates (Fig. 1A-D and S1I).”
- Also stated in: § ATG5 and Rubicon-deficiency exacerbate Aβ deposition and pathology · plain
“Likewise, both 5xFAD ATG5 LysM-cre+, 5xFAD Rubicon−/−, and 5xFAD Rubicon MG-cre+ mice showed early accumulation of Aβ within the cortex, whereas mice deficient for myeloid or microglial FIP200 were unaffected compared to LysM- or MG-cre− littermates (Fig. 1E,F and Fig. S1J,K).”
Quote in the paperSubstantial claim- Also stated in: § ATG5 and Rubicon-deficiency exacerbate Aβ deposition and pathology · plain
May combine two claims.
Findingown dataConditional deletion of Rubicon or FIP200 in microglia via CX3CR1-creERT2 ablates the genes in microglia but not in peripheral splenic macrophages.
“Primary microglia isolated from 5xFAD, Rubicon and FIP200, CX3CR1-creERT2 mice treated with tamoxifen at one month of age and allowed to reconstitute for 3 months (herein referred to as MG-cre+) showed ablation of Rubicon (Fig. S1F,G) or FIP200 (Fig. S1G), as indicated. In contrast, expression of each gene was restored in peripheral, splenic macrophages (Fig. S1H), as expected.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationAblation of Beclin1, VPS34, ATG5, ATG7, or Rubicon prevents recycling of TLR4, TREM2, and CD36, whereas ablation of ULK1, FIP200, or ATG14 has no effect.
“Ablation of Beclin1, VPS34, ATG5, or ATG7, required for both autophagy and LAP, prevented recycling of TLR4, TREM2, and CD36, as did Rubicon, required for LAP but not autophagy (Martinez et al., 2015). In contrast, no effects were seen upon ablation of ULK1, FIP200, or ATG14, all required for autophagy, but dispensable for LAP (Martinez et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Martinez et al., 2015 source
Not checked in the free run.
May combine two claims.
Findingown dataLoss of FIP200, ATG5, or Rubicon has no effect on primary uptake of Aβ, but secondary uptake is reduced in ATG5- and Rubicon-deficient cells and not in FIP200-deficient cells.
“Consistent with our clearance assay, the loss of FIP200, ATG5, or Rubicon had no effect on primary uptake of Aβ (Fig. 2G). We next added TAMRA-labeled Aβ1-42 and allowed for a second round of RME to occur. Again, we quantified the amount of internalized TAMR-1-42 and observed a reduction in secondary uptake in ATG5 and Rubicon-deficient cells but not those deficient in FIP200 (Fig. 2G).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeither microglial activation nor pro-inflammatory cytokine expression were altered in mice deficient in the 5xFAD transgene.
“Neither microglial activation nor pro-inflammatory cytokine expression were altered in mice deficient in the 5xFAD transgene (Fig. S5A,B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOver 90% of CD11b+ cells in brains from 5xFAD Rubicon+/− and −/− mice were TMEM119+, and TMEM119+ cells isolated from 5xFAD Rubicon−/− mice had higher Iba1 expression compared to Rubicon+/− animals.
“We observed that over 90% of CD11b+ cells in brains from the 5xFAD Rubicon+/− and−/− mice were TMEM119+ (a microglia-specific marker (Bennett et al., 2016)) (Fig. S5C,D). Furthermore, the TMEM119+ cells isolated from 5xFAD Rubicon−/− mice had higher Iba1 expression compared to Rubicon+/− animals (Fig. S5E).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bennett et al., 2016 source
Not checked in the free run.
May combine two claims.
Findingown dataSignificant increases in TNFα, IL-1β, IL-6, and a marginal increase in CCL5 occur within the hippocampus of 5xFAD Rubicon−/− and myeloid ATG5-deficient mice compared to control littermates.
“Using Iba1 expression as a positive control, we observed significant increases in TNFα, IL-1β, IL-6, and a marginal increase in CCL5 within the hippocampus of 5xFAD Rubicon−/− and myeloid ATG5-deficient mice compared to control littermates (Fig. 4G).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFIP200 deficiency has no impact on cytokine expression in response to Aβ1-42, whereas loss of LANDO in ATG5- and Rubicon-deficient cells results in a robust increase in all four pro-inflammatory genes evaluated.
“FIP200-deficiency failed to have any impact on cytokine expression in response to Aβ1-42 (Fig. 3D). However, loss of LANDO in both ATG5 and Rubicon-deficient cells resulted in a robust increase in all four pro-inflammatory genes evaluated (Fig. 3D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMyeloid or microglia-specific FIP200 deficiency has no effect on the extent of Iba1 expression in either the hippocampus or cortex of 5xFAD mice, whereas microglial hyperactivation is present in 5xFAD mice deficient in either Rubicon or myeloid ATG5.
“Consistent with our in vitro findings, myeloid or microglia-specific FIP200-deficiency had no effect on the extent of Iba1 expression in either the hippocampus or cortex of 5xFAD mice (Fig. 4A-C). In contrast, microglial hyperactivation was present in 5xFAD mice deficient in either Rubicon or myeloid ATG5 (Fig. 4A,B).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationBV2 cells treated with Aβ1-42 have elevated pro-inflammatory gene expression, including IL-1β, IL-6, CCL5, and TNFα.
“As expected, BV2 cells treated with Aβ1-42 had elevated pro-inflammatory gene expression, including IL-1β, IL-6, CCL5, and TNFα as reported (Pan et al., 2011) and consistent with human disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pan et al., 2011 source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
Findingown dataIn cells lacking ATG5 or Rubicon, phagosome maturation and LAMP1 association are diminished, while maturation and LAMP1 association of Aβ-containing endosomes are unaffected.
“Consistent with these reports, in the absence of Rubicon and ATG5, maturation of phagosomes was diminished as determined using pH-rodo-labeled zymosan, while maturation of endosomes containing pH-rodo-labeled Aβ was unaffected (Fig. 2E, S2E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRubicon or myeloid ATG5 deficiency leads to significant upregulation of pro-inflammatory cytokines at the transcriptional level in the brain, whereas myeloid FIP200 deficiency has no effect.
“Consistent with what we observed with cultured cells (Fig. 3), Rubicon- or myeloid ATG5-deficiency led to significant upregulation of pro-inflammatory cytokines at the transcriptional level in the brain, whereas myeloid FIP200-deficiency had no effect.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn RAW264.7 cells, TLR4, TREM2, and CD36 effectively recycle to the plasma membrane following antibody-induced internalization; this recycling is impaired upon Rubicon or ATG5 ablation, ATG4DN expression, or RavZ expression.
“To further explore this phenomenon, we employed the RAW264.7 myeloid cell line, and found that TLR4, TREM2, and CD36 effectively recycled to the plasma membrane following antibody-induced internalization. This recycling was dramatically impaired upon CRISPR/Cas9-mediated ablation of Rubicon or ATG5, upon expression of a dominant negative ATG4, or upon expression of the LC3-specific protease, RavZ”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFIP200 depletion has no effect on surface expression, internalization, or recycling of CD36, TLR4, or TREM2, whereas ATG5 or Rubicon ablation abrogates recycling of all three receptors while initial surface expression and internalization are unaffected.
“In BV2 microglia, depletion of FIP200 had no effect on either the surface expression, internalization (Fig. S2D), or recycling of CD36, TLR4, or TREM2 (Fig. 2H,I). Strikingly, ablation of either ATG5 and Rubicon led to abrogation of recycling for all three receptors (Fig. 2H,I) while initial surface expression and internalization were unaffected (Fig. S2D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAblation of either ATG5 or Rubicon has no effect on either the endocytosis or degradation of Aβ.
“Contrary to our assumptions, however, ablation of either ATG5 or Rubicon had no effect on either the endocytosis or degradation of Aβ (Fig. 2D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 in 5xFAD mice led to significant memory impairment.
“We observed that both global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 resulted in exacerbated Aβ deposition and plaque formation, reactive microgliosis, tau hyperphosphorylation, and neuronal cell death and dysfunction, leading to significant memory impairment.”
Quote in the paperSubstantial claim- Rests on an assumption: The 5xFAD mouse model is a well-characterized model of Aβ aggregate deposition and Alzheimer's disease.
May combine two claims.
Findingown dataThe paper observed no effects of their deletions on the rate of Aβ degradation, endosome maturation, or lysosome association.
“However, while LAP functions to promote phagosome maturation and cargo destruction (Heckmann et al., 2017), we observed no effects of our deletions on the rate of Aβ degradation, endosome maturation, or lysosome association (Fig. 2).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataNo variations in total fluid intake between genotypes were observed.
“No variations in total fluid intake between genotypes was observed (Fig. 7B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data5xFAD Rubicon−/− mice showed reduced hippocampal synaptic transmission and impaired long-term potentiation (LTP) compared to littermate controls.
“We found that 5xFAD Rubicon−/− mice showed a reduction in hippocampal synaptic transmission and, as a consequence, impaired long-term potentiation (LTP) when compared to littermate controls (Fig. 6E,F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMyeloid or microglia-specific FIP200 depletion has no impact on tau phosphorylation, whereas loss of either Rubicon (global or microglia-specific) or myeloid ATG5 promotes tau phosphorylation throughout the hippocampus and the cerebral cortex.
“Myeloid or microglia-specific FIP200 depletion had no impact on tau phosphorylation, however loss of either Rubicon (global or microglia-specific) or myeloid ATG5 promoted tau phosphorylation throughout the hippocampus (Fig. 5A,C, S6A) and the cerebral cortex (Fig. 5B,D, S6B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 in 5xFAD mice resulted in reactive microgliosis.
“We observed that both global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 resulted in exacerbated Aβ deposition and plaque formation, reactive microgliosis, tau hyperphosphorylation, and neuronal cell death and dysfunction, leading to significant memory impairment.”
Quote in the paperSubstantial claim- Rests on an assumption: The 5xFAD mouse model is a well-characterized model of Aβ aggregate deposition and Alzheimer's disease.
May combine two claims.
Findingown dataLC3 associates with endosomal markers Rab5 and clathrin at the membranes of Aβ-containing endosomes, and this association was not altered by inhibition of phagocytosis.
“Because we observed the association of LC3 and the endosomal markers Rab5 and clathrin at the membranes of Aβ-containing endosomes that was not altered by inhibition of phagocytosis, we called this LANDO.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 in 5xFAD mice resulted in exacerbated Aβ deposition and plaque formation.
“We observed that both global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 resulted in exacerbated Aβ deposition and plaque formation, reactive microgliosis, tau hyperphosphorylation, and neuronal cell death and dysfunction, leading to significant memory impairment.”
Quote in the paperSubstantial claim- Rests on an assumption: The 5xFAD mouse model is a well-characterized model of Aβ aggregate deposition and Alzheimer's disease.
May combine two claims.
Findingown data5xFAD Rubicon−/−, microglia-specific Rubicon-deficient, and myeloid ATG5-deficient mice all display a decrease in NeuN+ hippocampal neurons, whereas FIP200 deficiency has no impact on neuronal number.
“5xFAD Rubicon−/− microglia-specific Rubicon-deficient, and myeloid ATG5-deficient mice all displayed a decrease in NeuN+ hippocampal neurons (Fig. 6A,B). FIP200-deficiency had no impact on neuronal number.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 in 5xFAD mice resulted in neuronal cell death and dysfunction.
“We observed that both global and microglia-specific deletion of Rubicon and myeloid-specific deletion of ATG5 resulted in exacerbated Aβ deposition and plaque formation, reactive microgliosis, tau hyperphosphorylation, and neuronal cell death and dysfunction, leading to significant memory impairment.”
Quote in the paperSubstantial claim- Rests on an assumption: The 5xFAD mouse model is a well-characterized model of Aβ aggregate deposition and Alzheimer's disease.
May combine two claims.
Findingown dataULK1, FIP200, and ATG14 were dispensable for receptor recycling.
“We further found that Rubicon, ATG5, ATG7, and ATG4 were required, while ULK1, FIP200, and ATG14 were dispensable for this effect.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLoss of LANDO affected secondary uptake of Aβ, leading to increased extracellular deposition.
“However, loss of LANDO affected secondary uptake of Aβ, leading to increased extracellular deposition, and it is plausible that these deposits signal at the cell surface via other receptors to promote inflammatory signaling.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUse of CX3CR1-creERT2 to transiently ablate Rubicon resulted in Rubicon-deficient microglia but Rubicon-sufficient splenic macrophages at 4 months of age.
“Moreover, the use of CX3CR1- creERT2 to transiently ablate Rubicon resulted in Rubicon-deficient microglia but Rubicon-sufficient splenic macrophages at 4-months of age, but does not completely exclude the possibility that Rubicon-deficient peripheral monocytes may have entered the brain prior to reconstitution of this population from the bone marrow.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationExpression of several autophagy proteins, particularly Beclin1, ATG5, and ATG7, declines with age and is exacerbated in Alzheimer's disease.
“The expression of several autophagy proteins, in particular Beclin1, ATG5, and ATG7, decline with age, and is exacerbated in AD (Lipinski et al., 2010; Lucin et al., 2013; Pickford et al., 2008; Rubinsztein et al., 2011).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningIn response to Aβ, LANDO supports the clearance of Aβ deposits and prevents microglial activation, such that in its absence, inflammatory cytokine production and neurodegeneration proceed unchecked.
“In response to Aβ, LANDO supports the clearance of Aβ deposits and prevents microglial activation, such that in its absence, inflammatory cytokine production and neurodegeneration proceed unchecked.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPro-inflammatory cytokines and chemokines secreted into the immediate neurological environment accelerate neuronal injury and eventually neuron death.
“Pro-inflammatory cytokines and chemokines secreted into the immediate neurological environment accelerate neuronal injury and eventually neuron death (Aktas et al., 2007; Heckmann et al., 2018; Morales et al.,2014).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRubicon is an inhibitor of canonical autophagy and a key component of a non-canonical function of autophagy proteins that modulates inflammatory immune activation.
“Rubicon has been shown to be an inhibitor of canonical autophagy (Matsunaga et al., 2009) and a key component of a non-canonical function of autophagy proteins that modulates inflammatory immune activation (Cunha et al., 2018; Martinez et al., 2016).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationMicroglia are the principal mediators of inflammation in response to Aβ accumulation, and their contribution to neuroinflammation is highly correlated with progression of neurodegeneration and synaptic dysfunction, particularly in Alzheimer's disease.
“Microglia are the principal mediators of inflammation in response to Aβ accumulation (Machado et al., 2016; Perry and Holmes, 2014; Wang et al., 2015a), and their contribution to neuroinflammation is highly correlated to the progression of neurodegeneration and synaptic dysfunction, particularly with respect to Alzheimer’s disease (AD).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Machado et al., 2016 source
Not checked in the free run.
- cites Perry and Holmes, 2014
Not checked in the free run.
- cites Wang et al., 2015a
Not checked in the free run.
May combine two claims.
InterpretationreasoningLANDO may contribute to not only the regulation of aberrant Aβ deposition but also the immune activation of microglial cells in response to Aβ exposure.
“Taken as a whole, these data suggest LANDO may contribute to not only the regulation of aberrant Aβ deposition but also the immune activation of microglial cells in response to Aβ exposure.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHyperphosphorylation of tau is a marker of progressive Alzheimer's disease in both humans and mice; its incidence increases as disease progresses and leads to microtubule de-stabilization and failure of the microtubule architecture, especially within neuronal axons.
“A marker of progressive AD in both humans and mice is the hyperphosphorylation of the microtubule-stabilizing protein tau. The incidence of tau phosphorylation increases as disease progresses and leads to microtubule de-stabilization and failure of the microtubule architecture, especially within neuronal axons (Frost et al., 2015; Gong and Iqbal, 2008; Noble et al., 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataATG5 and Rubicon are necessary for recruitment of LC3 to Aβ-containing endosomes, whereas FIP200 is dispensable.
“Taken together, these data suggest that both ATG5 and Rubicon are necessary for recruitment of LC3 to Aβ-containing endosomes, whereas FIP200 is dispensable.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe requirements for recycling of TLR4, TREM2, and CD36 to the plasma membrane appear to be identical to those for LAP and distinct from those of autophagy.
“Therefore, the requirements for recycling of these receptors to the plasma membrane appear to be identical to those for LAP and distinct from those of autophagy.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationLAP has a vital role in regulating inflammatory immune responses.
“Since we have previously shown a vital role for LAP in regulating inflammatory immune responses (Martinez et al., 2016), we hypothesized that defective LANDO may have a similar effect.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Martinez et al., 2016 source
Not checked in the free run.
May combine two claims.
Interpretationown dataUptake of Aβ in BV2 cells occurs primarily through endocytosis (receptor-mediated endocytosis), as latrunculin A prevents zymosan internalization but has no effect on dextran or Aβ.
“Inhibition of actin polymerization and phagocytosis using latrunculin A (de Oliveira and Mantovani, 1988; Oliveira et al., 1996), prevented the internalization of the phagocytic substrate zymosan but had no effect on either the endocytic substrate dextran or Aβ (Fig. 2C), suggesting that uptake of Aβ in our model occurs primarily through endocytosis (RME).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites de Oliveira and Mantovani, 1988
Not checked in the free run.
- cites Oliveira et al., 1996 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningLANDO facilitates the recycling of internalized Aβ receptors to the plasma membrane, supporting continued rounds of endocytosis.
“Therefore, LANDO facilitates the recycling of internalized Aβ receptors to the plasma membrane, supporting continued rounds of endocytosis.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningLANDO is distinct from LAP and may have a unique role in Aβ clearance in vivo.
“Based on the association of LC3 to Aβ-containing endosomes, we propose the term LC3-Associated eNDOcytosis (LANDO) to describe this effect and suggest that LANDO is distinct from LAP and may have a unique role in Aβ clearance in vivo.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe results strongly suggest a role for microglial Rubicon and ATG5 in the clearance of Aβ and mitigation of microglial activation that is distinct from their functions in canonical autophagy.
“Therefore, our results strongly suggest a role for microglial Rubicon and ATG5 in the clearance of Aβ and mitigation of microglial activation that is distinct from their functions in canonical autophagy.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnhedonia can be analyzed in mice using the sucrose preference test (SPT).
“which can be analyzed in mice using a sucrose preference test (SPT) (Briones et al., 2012; Liu et al., 2018).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe CA3 field of the hippocampus has been implicated as one of the first sites of neuronal dysfunction and neuronal death in Alzheimer's disease.
“This region has been implicated as one of the first sites of neuronal dysfunction and neuronal death in AD (Belvindrah et al., 2014; Padurariu et al., 2012; Zhang et al., 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S4 (based).
Premisenone givenTau phosphorylation is likely to promote axonal degeneration and eventual neuronal death.
“Because tau phosphorylation is likely to promote axonal degeneration and eventual neuronal death, we analyzed cell death within the brains of our 5xFAD models.”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataThese analyses illustrate the importance of molecular regulation of microglial function by LANDO in maintaining CNS integrity and immune function upon Aβ deposition, allowing for homeostasis in memory and behavior.
“These analyses illustrate the importance for the molecular regulation of microglial function by LANDO in maintaining CNS integrity and immune function upon Aβ deposition, allowing for homeostasis in memory and behavior.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe paper's data support a physiological role for LANDO in microglia in mitigating microglial activation and immune-mediated aggregate Aβ removal.
“Our data support a physiological role for LANDO in microglia in the mitigation and protection against microglial activation and immune-mediated aggregate Aβ) removal.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn advanced AD, patients often complain of anhedonia.
“In advanced AD, patients often complain of anhedonia, or the inability to sense or experience pleasure (Naudin et al., 2015; Reichman and Coyne, 1995)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Naudin et al., 2015 source
Not checked in the free run.
- cites Reichman and Coyne, 1995
Not checked in the free run.
May combine two claims.
Study design and conductown dataAll animals were generated on the C57BL/6J background, confirmed by microsatellite analysis, so the differences observed do not reflect a background effect between strains.
“Moreover, all animals were generated on the C57BL/6J background which was confirmed by microsatellite analysis, therefore the differences observed do not reflect a background effect between strains.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIncreased cytokines, such as interleukin-1, can influence Aβ uptake.
“In turn, increased cytokines, such as interleukin-1, can influence Aβ uptake (Mrak and Griffin, 2000; Shaftel et al., 2007).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Mrak and Griffin, 2000
Not checked in the free run.
- cites Shaftel et al., 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSimilar effects were observed in response to dying cells in macrophages lacking Rac1 or the efferocytosis receptors merTK and TIM4.
“Similar effects were observed in response to dying cells in macrophages lacking Rac1 or the efferocytosis receptors merTK and TIM4 (Cai et al., 2018; Camenisch et al., 1999; Martinez et al., 2011; Scott et al., 2001; Thorp et al., 2008), consistent with this idea.”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA previous study showed that recycling of CD36 and TREM2 is dependent on Beclin1 and VPS34.
“A previous study had shown that this recycling of CD36 and TREM2 is dependent on Beclin1 and VPS34 (Lucin et al., 2013), which we confirmed in primary BMDM (Fig. 3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lucin et al., 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationWhole body acute deletion of ATG7 causes lethal neuronal degeneration.
“Whole body acute deletion of ATG7 causes lethal neuronal degeneration (Karsli-Uzunbas et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karsli-Uzunbas et al., 2014 source
Not checked in the free run.
May combine two claims.
Interpretationown dataLANDO functions in microglia not only to promote Aβ clearance but also to promote an anti-inflammatory immune response.
“Based on our findings using myeloid ATG5-deficiency and conditional ablation of Rubicon in microglia, we suggest that LANDO functions in microglia not only to promote Aβ clearance but also to promote an anti-inflammatory immune response.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAutophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by canonical aggrephagy.
“While autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), effects in microglia of the CNS are more likely due to LANDO.”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe assay used does not evaluate the role of LANDO in receptor degradation or other potential perturbations in endosome trafficking.
“The assay used herein does not evaluate the role of LANDO in receptor degradation, or other potential perturbations in endosome trafficking, and it remains possible that such alterations alter receptor signaling to promote cytokine expression in response to Aβ.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningLANDO is distinct from canonical autophagy and plays a requisite role in the recycling of putative Aβ receptors.
“We conclude that LANDO is distinct from canonical autophagy and plays a requisite role in the recycling of putative Aβ receptors.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataBV2 microglia deficient in FIP200, ATG5, and Rubicon were generated using CRISPR/Cas9, and transduction efficiency was confirmed by immunoblot analysis.
“BV2 microglia deficient in FIP200, ATG5, and Rubicon were generated using CRISPR/Cas9 technology by lentiviral transduction and puromycin selection.”
- Also stated in: § METHOD DETAILS · plain
“BV2 cells were subsequently transduced and transduction efficiency was confirmed by immunoblot analysis following two weeks of puromycin selection.”
Quote in the paperSubstantial claim- Also stated in: § METHOD DETAILS · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll experiments were designed and powered to a minimum of 0.8 as calculated using G*Power.
“All experiments were designed and are powered to a minimum of 0.8 as calculated using G*Power.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe membrane-associated LC3 analysis assay has been well-established and verified previously.
“This assay has been well-established and verified previously (Eng et al., 2010; He et al., 2009; Martinez et al., 2015).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenFollowing the receptor recycling protocol, fluorescent signal from recycled receptors is intracellular and readily determined by fluorescent microscopy.
“Following the above protocol, fluorescent signal from recycled receptors is intracellular and readily determined by fluorescent microscopy as described above.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenMG-cre− animals were exposed to tamoxifen and allowed the same reconstitution period as MG-cre+ mice to ensure no off-target effects from tamoxifen administration.
“MG-cre− animals used in the present study have been exposed to tamoxifen and allowed the same reconstitution period as the MG-cre+ mice to ensure no off-target effects from tamoxifen administration.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSpecificity of the antibody targeting TREM2 was confirmed by staining wild-type and TREM2−/− BV2 microglial cells (data not shown).
“Specificity of the antibody targeting the primary β-amyloid receptor TREM2 was confirmed by staining wild-type and TREM2 −/− BV2 microglial cells (data not shown).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAll strains used had an overall background identity of greater than 97%.
“All strains used had an overall background identity of greater than 97%.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAll cell lines used were confirmed as mycoplasma negative.
“All the cell lines used were confirmed as mycoplasma negative using MycoAlert Mycoplasma Detection kit (Lonza #LT07).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe receptor recycling method is well-established and was used as previously reported by Lucin et al. (2013).
“This method is well-established and used as previously reported (Lucin et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lucin et al., 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMice with fewer than 5 arm entries during the 5-minute Y-maze trial were excluded from the analysis.
“Mice with less than 5 arm entries during the 5 min. trial were excluded from the analysis.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
BV2 murine microglial cells are a valid model of primary microglia for studying LANDO and Aβ responses.
“we engineered BV2 murine microglial cells expressing GFP-LC3 that are deficient in FIP200, ATG5, or Rubicon using CRISPR/Cas9 (Fig. S2A).”
The paper relies on this without support.
The 5xFAD mouse model is a well-characterized model of Aβ aggregate deposition and Alzheimer's disease.
“We employed a well-characterized model of Aβ aggregate deposition, the 5xFAD AD mouse model with genetic manipulation of our target autophagy-related genes.”
The paper relies on this without support.
The behavioral tests used are well-characterized and known to be affected at late stages in the 5xFAD model.
“We therefore subjected mice to a variety of well-characterized behavioral tests known to be affected at late stages in the 5xFAD model.”
The paper relies on this without support.
The commercially available antibodies for CD36, TLR4, and TREM2 used in the recycling experiments are validated and specific.
“Furthermore, validated commercially available antibodies for CD36, TLR4, and TREM2 were used for all recycling experiments.”
The paper relies on this without support.
Latrunculin A inhibits phagocytosis but not endocytosis, allowing delineation between the two processes.
“To delineate between phagocytosis and endocytosis, cells were treated as indicated with the phagocytic inhibitor latrunculin A.”
The paper relies on this without support.
Zymosan is a specific control substrate for phagocytosis and dextran is a specific control substrate for endocytosis.
“The following control substrates were used, zymosan (phagocytosis) and dextran (endocytosis)”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Microglia promote the uptake and degradation of Aβ.
“Considerable evidence has found that microglia promote the uptake and degradation of Aβ.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [146]
In 5xFAD mice, further accumulation of LC3-II and p62 is observed compared to WT mice.
“Consistent with previous reports [50, 118], further accumulation of LC3-II and p62 was observed in 5xFAD mice when compared to WT mice.”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting sources for BV2 cells
MinorThe key resources table lists Washington University as the source of BV2 microglia, but the methods state that the BV2 cells were obtained from ATCC.
“| BV2 murine microglia | Washington University | Herbert Virgin |”
“BV2 murine microglia and RAW264.7 cells were obtained from ATCC.”
Cites
3 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758 · cited 17× · see citing works
“Deficiencies in LAP have been shown to reduce the ability of a cell to degrade phagosome cargo, including dying cells, fungi, and bacteria by impairing phagosome maturation and lysosomal interaction (Heckmann et al., 2017; Heckmann and Green, 2019; Martinez et al., 2011; Martinez et al., 2016; Martinez et al., 2015).”
InfluentialSelf-citationRetractedMartinez, J., Almendinger, J., Oberst, A., Ness, R., Dillon, C. P., Fitzgerald, P., Hengartner, M. O., & Green, D. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113421108 · Cited by 655 · cited 3× · see citing works
“2B) as measured by flow cytometry and described previously (Eng et al., 2010; He et al., 2009; Martinez et al., 2011; Martinez et al., 2015).”
Self-citationRetractedMartinez, J., Cunha, L. D., Park, S., Yang, M., Lu, Q., Orchard, R., Li, Q.-Z., Yan, M., Janke, L., Guy, C., et al. (2016) · Nature · doi:10.1038/nature17950 · Cited by 381 · cited 3× · see citing works
“Since we have previously shown a vital role for LAP in regulating inflammatory immune responses (Martinez et al., 2016), we hypothesized that defective LANDO may have a similar effect.”
Self-citationRetractedOakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1× · see citing works
“Cg-Tg (APPSwFILon, PSEN1 *M146L*L286V) 6799Vas) model (Oakley et al., 2006).”
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · cited 2× · see citing works
“Roles for autophagy have been explored in the context of neuronal function, homeostasis, and alterations leading to disease pathology and neuronal dysfunction (Colacurcio et al., 2018; Ejlerskov et al., 2019; Harris and Rubinsztein, 2011; Menzies et al., 2017; Rubinsztein et al., 2015).”
Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,997 · cited 1× · see citing works
“Microglia can undergo pro-inflammatory, classical (M1) or anti-inflammatory, alternative (M2) activation depending on which immune receptor is engaged, resulting in the activation of multiple downstream intracellular signaling pathways (Wang et al., 2014).”
New tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804 · cited 1× · see citing works
“We observed that over 90% of CD11b+ cells in brains from the 5xFAD Rubicon+/− and−/− mice were TMEM119+ (a microglia-specific marker (Bennett et al., 2016)) (Fig.”
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · see citing works
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429 · cited 1× · see citing works
“…in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), effects in microglia of the CNS are more likely due to LANDO.”
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394 · cited 4× · see citing works
“The requirement for ATG4, which converts LC3 to LC3-I (Kabeya et al., 2004) and the effect of RavZ, which irreversibly cleaves lipidated LC3 (Choy et al.”
InfluentialRole of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288 · see citing works
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263 · cited 1× · see citing works
“Furthermore, since TREM2 is the most well-characterized Aβ receptor that activates Aβ endocytosis (Doens and Fernandez, 2014; Ries and Sastre, 2016; Ulland et al., 2017; Wang et al., 2015b; Zhao et al., 2018), we evaluated TREM2 recycling in primary microglia cells isolated from Rubicon−/− mice.”
Matsunaga, K., Saitoh, T., Tabata, K., Omori, H., Satoh, T., Kurotori, N., Maejima, I., Shirahama-Noda, K., Ichimura, T., Isobe, T., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1846 · Cited by 1,235 · cited 1× · see citing works
“Rubicon has been shown to be an inhibitor of canonical autophagy (Matsunaga et al., 2009) and a key component of a noncanonical function of autophagy proteins that modulates inflammatory immune activation (Cunha et al.”
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 1× · see citing works
“Similar effects were observed in response to dying cells in macrophages lacking Rac1 or the efferocytosis receptors merTK and TIM4 (Cai et al., 2018; Camenisch et al., 1999; Martinez et al., 2011; Scott et al., 2001; Thorp et al., 2008), consistent with this idea.”
Pickford, F., Masliah, E., Britschgi, M., Lucin, K. M., Narasimhan, R., Jaeger, P. A., Small, S., Spencer, B., Rockenstein, E., Levine, B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33585 · Cited by 1,186 · cited 1× · see citing works
“The expression of several autophagy proteins, in particular Beclin1, ATG5, and ATG7, decline with age, and is exacerbated in AD (Lipinski et al., 2010; Lucin et al., 2013; Pickford et al., 2008; Rubinsztein et al., 2011).”
Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A., & Rubinsztein, D. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609532200 · Cited by 1,142 · see citing works
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.022 · Cited by 1,134 · cited 2× · see citing works
“While autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), ef…”
Microglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127 · cited 1× · see citing works
“Microglia are the principal mediators of inflammation in response to Aβ accumulation (Machado et al., 2016; Perry and Holmes, 2014; Wang et al., 2015a), and their contribution to neuroinflammation is highly correlated to the progression of neurodegeneration and synaptic dysfunction, particularly with respect to Alzhei…”
Sucrose preference test for measurement of stress-induced anhedonia in mice
Liu, M.-Y., Yin, C.-Y., Zhu, L.-J., Zhu, X.-H., Xu, C., Luo, C.-X., Chen, H., Zhu, D.-Y., & Zhou, Q.-G. (2018) · Nature Protocols · doi:10.1038/s41596-018-0011-z · Cited by 1,026 · see citing works
Systemic inflammation and microglial activation: systematic review of animal experiments
Hoogland, I. C. M., Houbolt, C., van Westerloo, D. J., van Gool, W. A., & van de Beek, D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0332-6 · Cited by 957 · cited 1× · see citing works
“Using Iba1 as a marker for microglial activation (Hoogland et al., 2015), we assessed hippocampal and cortical sections to evaluate microglial activation.”
Microglial Activation and its Implications in the Brain Diseases
Dheen, S. T., Kaur, C., & Ling, E. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780597961 · Cited by 954 · cited 1× · see citing works
“Upon binding of ligands such as Aβ, microglial cells internalize the target by receptor-mediated endocytosis (RME), leading to activation of signaling pathways and cytokine production in a ligand-dependent manner (Dheen et al., 2007).”
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840 · cited 2× · see citing works
“A previous study utilized parabiosis to evaluate the contribution of circulating monocytes to the microglial pool in 5xFAD mice and demonstrated a negligible contribution of peripheral cells (Wang et al., 2016).”
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Zhao, Y., Wu, X., Li, X., Jiang, L.-L., Gui, X., Liu, Y., Sun, Y., Zhu, B., Piña-Crespo, J. C., Zhang, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.031 · Cited by 763 · cited 2× · see citing works
“…toll-like receptors (TLRs) (Gurley et al., 2008), Fc receptors (Fuller et al., 2014), Ig-superfamily receptors including TREM2 (Ulrich et al., 2014; Wang et al., 2016; Zhao et al., 2018), scavenger receptors (SR) (Wilkinson and El Khoury, 2012) and complement receptors (Doens and Fernandez, 2014).”
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688 · cited 2× · see citing works
“CX3CR1-creERT2 mice were purchased from the Jackson Laboratory and conditional deletion of FIP200 or Rubicon was achieved using tamoxifen induction and peripheral reconstitution as described previously (Goldmann et al., 2013).”
Lipinski, M. M., Zheng, B., Lu, T., Yan, Z., Py, B. F., Ng, A., Xavier, R. J., Li, C., Yankner, B. A., Scherzer, C. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009485107 · Cited by 680 · cited 2× · see citing works
“The expression of these three proteins decreases with age (Lipinski et al., 2010), which may lead to an insufficiency in LANDO, establishing a putative risk factor for pathology.”
Kim, Y. S., & Joh, T. H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.40 · Cited by 655 · cited 1× · see citing works
“Hyperactivation of microglia leads to the morphological transition of cells from the ramified to the inflammatory ameboid state (Kim and Joh, 2006).”
Gong, C., & Iqbal, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909111 · Cited by 649 · cited 1× · see citing works
“The incidence of tau phosphorylation increases as disease progresses and leads to microtubule de-stabilization and failure of the microtubule architecture, especially within neuronal axons (Frost et al., 2015; Gong and Iqbal, 2008; Noble et al., 2013).”
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591 · cited 1× · see citing works
“Therefore, we examined the role of FIP200, ATG5, and Rubicon in recycling of TREM2, CD36, and TLR4 (suggested to be a putative Aβ receptor (Reed-Geaghan et al., 2009; Song et al., 2011).”
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583 · cited 1× · see citing works
“Aβ, especially the Aβ1-42 oligomer and fibril, is an established instigator of neuroinflammation (Cai et al., 2014).”
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565 · see citing works
Autophagy is required for glucose homeostasis and lung tumor maintenance
Karsli-Uzunbas, G., Guo, J. Y., Price, S., Teng, X., Laddha, S. V., Khor, S., Kalaany, N. Y., Jacks, T., Chan, C. S., Rabinowitz, J. D., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0363 · Cited by 560 · cited 1× · see citing works
“Whole body acute deletion of ATG7 causes lethal neuronal degeneration (Karsli-Uzunbas et al., 2014).”
Mechanisms of Aβ Clearance and Degradation by Glial Cells
Ries, M., & Sastre, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00160 · Cited by 527 · cited 1× · see citing works
“Furthermore, since TREM2 is the most well-characterized Aβ receptor that activates Aβ endocytosis (Doens and Fernandez, 2014; Ries and Sastre, 2016; Ulland et al., 2017; Wang et al., 2015b; Zhao et al., 2018), we evaluated TREM2 recycling in primary microglia cells isolated from Rubicon−/− mice.”
Abram, C. L., Roberge, G., Hu, Y., & Lowell, C. A. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.05.009 · Cited by 507 · cited 1× · see citing works
“The 5xFAD transgene was crossed into mice with conditional ablation of the key autophagy regulators FIP200 and ATG5 using lysozyme M (LysM/Lyz2)-Cre-lox recombination, which targets cells of the myeloid lineage and microglia, with an efficiency ranging from 40-90% in microglia (Abram et al., 2014; Ferro et al., 2018;…”
Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function
Lenz, K. M., & Nelson, L. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00698 · Cited by 491 · cited 1× · see citing works
“Although distinct from peripheral macrophages (Lenz and Nelson, 2018), microglia have the ability to recognize pathogens and other inflammatory stimulants by virtue of a host of receptors including toll-like receptors (TLRs) (Gurley et al.”
Morales, I., Guzmán-MartÃnez, L., Cerda-Troncoso, C., FarÃas, G. A., & Maccioni, R. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00112 · Cited by 490 · see citing works
The importance of tau phosphorylation for neurodegenerative diseases
Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475 · cited 1× · see citing works
“The incidence of tau phosphorylation increases as disease progresses and leads to microtubule de-stabilization and failure of the microtubule architecture, especially within neuronal axons (Frost et al., 2015; Gong and Iqbal, 2008; Noble et al., 2013).”
The <i>Legionella</i> Effector RavZ Inhibits Host Autophagy Through Irreversible Atg8 Deconjugation
Choy, A., Dancourt, J., Mugo, B., O’Connor, T. J., Isberg, R. R., Melia, T. J., & Roy, C. R. (2012) · Science · doi:10.1126/science.1227026 · Cited by 473 · cited 2× · see citing works
“, 2004) and the effect of RavZ, which irreversibly cleaves lipidated LC3 (Choy et al., 2012; Kwon et al., 2017), strongly suggest that lipidation of LC3-family proteins is required for recycling of these receptors.”
Control of autophagy as a therapy for neurodegenerative disease
Harris, H., & Rubinsztein, D. C. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.200 · Cited by 445 · cited 1× · see citing works
“Roles for autophagy have been explored in the context of neuronal function, homeostasis, and alterations leading to disease pathology and neuronal dysfunction (Colacurcio et al., 2018; Ejlerskov et al., 2019; Harris and Rubinsztein, 2011; Menzies et al., 2017; Rubinsztein et al., 2015).”
TLR2 Is a Primary Receptor for Alzheimer’s Amyloid β Peptide To Trigger Neuroinflammatory Activation
Liu, S., Liu, Y., Hao, W., Wolf, L., Kiliaan, A. J., Penke, B., Rübe, C. E., Walter, J., Heneka, M. T., Hartmann, T., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101121 · Cited by 439 · cited 1× · see citing works
“It is currently believed that cooperation between several of these receptor families is responsible for the recognition of and response to Aβpeptide oligomers and amyloids (Aβ) by microglial cells (Doens and Fernandez, 2014; Liu et al., 2012).”
Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · cited 1× · see citing works
“In turn, increased cytokines, such as interleukin-1, can influence Aβ uptake (Mrak and Griffin, 2000; Shaftel et al., 2007).”
Eimer, W. A., & Vassar, R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-2 · Cited by 425 · cited 1× · see citing works
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript month old 5xFAD Rubicon−/− mice (Eimer and Vassar, 2013).”
Lucin, K. M., O’Brien, C. E., Bieri, G., Czirr, E., Mosher, K. I., Abbey, R. J., Mastroeni, D. F., Rogers, J., Spencer, B., Masliah, E., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.046 · Cited by 374 · cited 10× · see citing works
“This method is well-established and used as previously reported (Lucin et al., 2013).”
InfluentialThorp, E., Cui, D., Schrijvers, D. M., Kuriakose, G., & Tabas, I. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.167197 · Cited by 357 · cited 1× · see citing works
“Similar effects were observed in response to dying cells in macrophages lacking Rac1 or the efferocytosis receptors merTK and TIM4 (Cai et al., 2018; Camenisch et al., 1999; Martinez et al., 2011; Scott et al., 2001; Thorp et al., 2008), consistent with this idea.”
Doens, D., & Fernández, P. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-48 · Cited by 348 · cited 4× · see citing works
“…toll-like receptors (TLRs) (Gurley et al., 2008), Fc receptors (Fuller et al., 2014), Ig-superfamily receptors including TREM2 (Ulrich et al., 2014; Wang et al., 2016; Zhao et al., 2018), scavenger receptors (SR) (Wilkinson and El Khoury, 2012) and complement receptors (Doens and Fernandez, 2014).”
InfluentialLC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance
Cunha, L. D., Yang, M., Carter, R., Guy, C., Harris, L., Crawford, J. C., Quarato, G., Boada-Romero, E., Kalkavan, H., Johnson, M. D. L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.061 · Cited by 334 · cited 2× · see citing works
“, 2009) and a key component of a noncanonical function of autophagy proteins that modulates inflammatory immune activation (Cunha et al., 2018; Martinez et al., 2016).”
Self-citationAutophagy and neurodegeneration
Frake, R. A., Ricketts, T., Menzies, F. M., & Rubinsztein, D. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73944 · Cited by 332 · cited 1× · see citing works
“While autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), ef…”
Camenisch, T. D., Koller, B. H., Earp, H. S., & Matsushima, G. K. (1999) · PubMed · Cited by 321 · see citing works
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302 · cited 2× · see citing works
“, 2014), Ig-superfamily receptors including TREM2 (Ulrich et al., 2014; Wang et al., 2016; Zhao et al., 2018), scavenger receptors (SR) (Wilkinson and El Khoury, 2012) and complement receptors (Doens and Fernandez, 2014).”
Pan, X.-D., Zhu, Y.-G., Lin, N., Zhang, J., Ye, Q.-Y., Huang, H.-P., & Chen, X.-C. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-45 · Cited by 292 · cited 1× · see citing works
“As expected, BV2 cells treated with Aβ1-42 had elevated pro-inflammatory gene expression, including IL-1β, IL-6, CCL5, and TNFα as reported (Pan et al., 2011) and consistent with human disease.”
Camenisch, T. D., Koller, B. H., Earp, H. S., & Matsushima, G. K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3498 · Cited by 290 · cited 1× · see citing works
“Similar effects were observed in response to dying cells in macrophages lacking Rac1 or the efferocytosis receptors merTK and TIM4 (Cai et al., 2018; Camenisch et al., 1999; Martinez et al., 2011; Scott et al., 2001; Thorp et al., 2008), consistent with this idea.”
LC3-Associated Phagocytosis and Inflammation
Heckmann, B. L., Boada-Romero, E., Cunha, L. D., Magne, J., & Green, D. R. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.08.012 · Cited by 276 · cited 3× · see citing works
“Deficiencies in LAP have been shown to reduce the ability of a cell to degrade phagosome cargo, including dying cells, fungi, and bacteria by impairing phagosome maturation and lysosomal interaction (Heckmann et al., 2017; Heckmann and Green, 2019; Martinez et al., 2011; Martinez et al., 2016; Martinez et al., 2015).”
Self-citationSong, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-92 · Cited by 273 · cited 1× · see citing works
“Therefore, we examined the role of FIP200, ATG5, and Rubicon in recycling of TREM2, CD36, and TLR4 (suggested to be a putative Aβ receptor (Reed-Geaghan et al., 2009; Song et al., 2011).”
LC3-associated phagocytosis at a glance
Heckmann, B. L., & Green, D. R. (2019) · Journal of Cell Science · doi:10.1242/jcs.222984 · Cited by 272 · cited 1× · see citing works
“…have been shown to reduce the ability of a cell to degrade phagosome cargo, including dying cells, fungi, and bacteria by impairing phagosome maturation and lysosomal interaction (Heckmann et al., 2017; Heckmann and Green, 2019; Martinez et al., 2011; Martinez et al., 2016; Martinez et al., 2015).”
Self-citationNeuronal damage in brain inflammation
Aktas, O., Ullrich, O., Infante-Duarte, C., Nitsch, R., & Zipp, F. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.185 · Cited by 249 · see citing works
(2012) · PubMed · Cited by 248 · see citing works
Therapeutic targeting of autophagy in neurodegenerative and infectious diseases
Rubinsztein, D. C., Bento, C. F., & Deretic, V. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150956 · Cited by 202 · cited 1× · see citing works
“Roles for autophagy have been explored in the context of neuronal function, homeostasis, and alterations leading to disease pathology and neuronal dysfunction (Colacurcio et al., 2018; Ejlerskov et al., 2019; Harris and Rubinsztein, 2011; Menzies et al., 2017; Rubinsztein et al., 2015).”
Microglial Scavenger Receptors and Their Roles in the Pathogenesis of Alzheimer's Disease
Wilkinson, K., & Khoury, J. B. E. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/489456 · Cited by 186 · see citing works
Assaying autophagic activity in transgenic GFP-Lc3 and GFP-Gabarap zebrafish embryos
He, C., Bartholomew, C. R., Zhou, W., & Klionsky, D. J. (2009) · Autophagy · doi:10.4161/auto.5.4.7768 · Cited by 181 · cited 2× · see citing works
“2B) as measured by flow cytometry and described previously (Eng et al., 2010; He et al., 2009; Martinez et al., 2011; Martinez et al., 2015).”
Cai, B., Kasikara, C., Doran, A. C., Ramakrishnan, R., Birge, R. B., & Tabas, I. (2018) · Science Signaling · doi:10.1126/scisignal.aar3721 · Cited by 175 · cited 1× · see citing works
“Similar effects were observed in response to dying cells in macrophages lacking Rac1 or the efferocytosis receptors merTK and TIM4 (Cai et al., 2018; Camenisch et al., 1999; Martinez et al., 2011; Scott et al., 2001; Thorp et al., 2008), consistent with this idea.”
Colacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167 · cited 1× · see citing works
“Roles for autophagy have been explored in the context of neuronal function, homeostasis, and alterations leading to disease pathology and neuronal dysfunction (Colacurcio et al., 2018; Ejlerskov et al., 2019; Harris and Rubinsztein, 2011; Menzies et al., 2017; Rubinsztein et al., 2015).”
New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease
Fuller, J. P., Stavenhagen, J. B., & Teeling, J. L. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00235 · Cited by 154 · cited 1× · see citing works
“, 2008), Fc receptors (Fuller et al., 2014), Ig-superfamily receptors including TREM2 (Ulrich et al.”
The elimination of accumulated and aggregated proteins: A role for aggrephagy in neurodegeneration
Yamamoto, A., & Simonsen, A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.015 · Cited by 152 · cited 1× · see citing works
“While autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), ef…”
A novel quantitative flow cytometry-based assay for autophagy
Eng, K. E., Panas, M. D., Hedestam, G. B. K., & McInerney, G. M. (2010) · Autophagy · doi:10.4161/auto.6.5.12112 · Cited by 151 · cited 2× · see citing works
“2B) as measured by flow cytometry and described previously (Eng et al., 2010; He et al., 2009; Martinez et al., 2011; Martinez et al., 2015).”
Crashing the computer: apoptosis vs. necroptosis in neuroinflammation
Heckmann, B. L., Tummers, B., & Green, D. R. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0195-3 · Cited by 132 · see citing works
Self-citationConnecting the dots between tau dysfunction and neurodegeneration
Frost, B., Götz, J., & Feany, M. B. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.005 · Cited by 124 · cited 1× · see citing works
“The incidence of tau phosphorylation increases as disease progresses and leads to microtubule de-stabilization and failure of the microtubule architecture, especially within neuronal axons (Frost et al., 2015; Gong and Iqbal, 2008; Noble et al., 2013).”
Mechanisms of neuronal homeostasis: Autophagy in the axon
Maday, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.047 · Cited by 123 · cited 1× · see citing works
“While axonal autophagy has been implicated as a protective mechanism in the early stages of neurodegeneration (Maday, 2016), the functions of autophagy proteins are less well characterized in the context of microglia and immune activation.”
Interleukin-1 and the Immunogenetics of Alzheimer Disease
Mrak, R. E., & Griffin, W. S. T. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.6.471 · Cited by 119 · cited 1× · see citing works
“In turn, increased cytokines, such as interleukin-1, can influence Aβ uptake (Mrak and Griffin, 2000; Shaftel et al., 2007).”
Girard, S. D., Jacquet, M., Baranger, K., Migliorati, M., Escoffier, G., Bernard, A., Khrestchatisky, M., Féron, F., Rivera, S., Roman, F. S., et al. (2014) · Hippocampus · doi:10.1002/hipo.22267 · Cited by 119 · cited 1× · see citing works
“Interestingly, behavioral and memory deficits do not typically begin to show significant differences in 5xFAD animals until at least 5-7 months of age (Girard et al., 2014; Ohno, 2009).”
Orthgieß, J., Gericke, M. T., Immig, K., Schulz, A., Hirrlinger, J., Bechmann, I., & Eilers, J. (2016) · European Journal of Immunology · doi:10.1002/eji.201546108 · Cited by 111 · cited 1× · see citing works
“It has also been suggested that LysM-cre can produce off-target effects in neurons (Orthgiess et al., 2016).”
Failures to reconsolidate memory in a mouse model of Alzheimer’s disease
Ohno, M. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.05.001 · Cited by 95 · cited 1× · see citing works
“Interestingly, behavioral and memory deficits do not typically begin to show significant differences in 5xFAD animals until at least 5-7 months of age (Girard et al., 2014; Ohno, 2009).”
Chapter 5 Autophagic Clearance of Aggregate‐Prone Proteins Associated with Neurodegeneration
Sarkar, S., Ravikumar, B., & Rubinsztein, D. C. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)04005-6 · Cited by 91 · cited 1× · see citing works
“While autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), ef…”
Vps35-dependent recycling of Trem2 regulates microglial function
Yin, J., Liu, X., He, Q., Zhou, L., Yuan, Z., & Zhao, S. (2016) · Traffic · doi:10.1111/tra.12451 · Cited by 90 · cited 2× · see citing works
“According to the receptor-recycling method we employed and established by others (Lucin et al., 2013; Yin et al., 2016), we found that LANDO is required for the recycling of putative Aβ receptors (CD36, TREM2, and TLR4) from internalized endosomes to the plasma membrane.”
Microglia and Astrocyte Activation by Toll‐Like Receptor Ligands: Modulation by PPAR‐γ Agonists
Gurley, C. M., Nichols, J. R., Liu, S., Phulwani, N. K., Esen, N., & Kielian, T. (2008) · PPAR Research · doi:10.1155/2008/453120 · Cited by 84 · cited 1× · see citing works
“…have the ability to recognize pathogens and other inflammatory stimulants by virtue of a host of receptors including toll-like receptors (TLRs) (Gurley et al., 2008), Fc receptors (Fuller et al., 2014), Ig-superfamily receptors including TREM2 (Ulrich et al., 2014; Wang et al., 2016; Zhao et…”
Machado, V., Zöller, T., Attaai, A., & Spittau, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020151 · Cited by 76 · cited 2× · see citing works
“Microglia are the principal mediators of inflammation in response to Aβ accumulation (Machado et al., 2016; Perry and Holmes, 2014; Wang et al., 2015a), and their contribution to neuroinflammation is highly correlated to the progression of neurodegeneration and synaptic dysfunction, particularly with respect to Alzhei…”
Stress-induced anhedonia is associated with an increase in Alzheimer’s disease-related markers
Briones, A., Gagno, S., Martisova, E., Dobarro, M., Aisa, B., Solas, M., Tordera, R., & Ramírez, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01602.x · Cited by 64 · cited 4× · see citing works
“, 2015; Reichman and Coyne, 1995), which can be analyzed in mice using a sucrose preference test (SPT) (Briones et al., 2012; Liu et al., 2018).”
InfluentialDepressive Symptoms in Alzheimer's Disease and Multi-infarct Dementia
Reichman, W. E., & Coyne, A. C. (1995) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879500800203 · Cited by 53 · cited 1× · see citing works
“In advanced AD, patients often complain of anhedonia, or the inability to sense or experience pleasure (Naudin et al., 2015; Reichman and Coyne, 1995), which can be analyzed in mice using a sucrose preference test (SPT) (Briones et al.”
Latrunculin A is a potent inhibitor of phagocytosis by macrophages
de Oliveira, C. A., & Mantovani, B. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90282-2 · Cited by 50 · see citing works
Zhang, Q.-G., Wang, R.-M., Scott, E., Han, D., Dong, Y., Tu, J.-Y., Yang, F., Reddy Sareddy, G., Vadlamudi, R. K., & Brann, D. W. (2013) · Brain · doi:10.1093/brain/awt046 · Cited by 50 · cited 1× · see citing works
“This region has been implicated as one of the first sites of neuronal dysfunction and neuronal death in AD (Belvindrah et al., 2014; Padurariu et al., 2012; Zhang et al., 2013).”
Oliveira, C. A., Kashman, Y., & Mantovani, B. (1996) · Chemico-Biological Interactions · doi:10.1016/0009-2797(96)03695-2 · Cited by 43 · cited 1× · see citing works
“Inhibition of actin polymerization and phagocytosis using latrunculin A (de Oliveira and Mantovani, 1988; Oliveira et al., 1996), prevented the internalization of the phagocytic substrate zymosan but had no effect on either the endocytic substrate dextran or Aβ (Fig.”
Kwon, D. H., Kim, S., Jung, Y. O., Roh, K.-H., Kim, L., Kim, B.-W., Hong, S. B., Lee, I. Y., Song, J. H., Lee, W. C., et al. (2017) · Autophagy · doi:10.1080/15548627.2016.1243199 · Cited by 43 · cited 2× · see citing works
“, 2004) and the effect of RavZ, which irreversibly cleaves lipidated LC3 (Choy et al., 2012; Kwon et al., 2017), strongly suggest that lipidation of LC3-family proteins is required for recycling of these receptors.”
Pulido-Salgado, M., Vidal-Taboada, J. M., Barriga, G. G.-D., Serratosa, J., Valente, T., Castillo, P., Matalonga, J., Straccia, M., Canals, J. M., Valledor, A. F., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0834-5 · Cited by 37 · see citing works
The activation of autophagy protects neurons and astrocytes against bilirubin-induced cytotoxicity
Qaisiya, M., Mardešić, P., Pastore, B., Tiribelli, C., & Bellarosa, C. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.056 · Cited by 35 · cited 1× · see citing works
“While autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), ef…”
Ferro, A., Qu, W., Lukowicz, A., Svedberg, D. A., Johnson, A., & Cvetanović, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200013 · Cited by 26 · see citing works
Gingras, S., Earls, L. R., Howell, S., Smeyne, R. J., Zakharenko, S. S., & Pelletier, S. W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2056-14.2015 · Cited by 23 · cited 1× · see citing works
“Electrophysiology—Acute transverse hippocampal slices (400 μm) were prepared as previously described (Gingras et al., 2015).”
Self-citationCorrection: LC3-associated phagocytosis at a glance (doi:10.1242/jcs.222984)
Heckmann, B. L., & Green, D. R. (2019) · Journal of Cell Science · doi:10.1242/jcs.231472 · Cited by 21 · see citing works
Self-citationInhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
Park, S.-K., Ratia, K. M., Ba, M. A., Valencik, M. L., & Liebman, S. W. (2016) · Microbial Cell · doi:10.15698/mic2016.02.476 · Cited by 20 · cited 1× · see citing works
“It is possible that this was due to the described ability of tamoxifen, given to all of the MG-cre animals, to reduce oligomerization of Aβ (Park et al., 2016).”
Genetic enhancement of macroautophagy in vertebrate models of neurodegenerative diseases
Ejlerskov, P., Ashkenazi, A., & Rubinsztein, D. C. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.001 · Cited by 20 · cited 1× · see citing works
“Roles for autophagy have been explored in the context of neuronal function, homeostasis, and alterations leading to disease pathology and neuronal dysfunction (Colacurcio et al., 2018; Ejlerskov et al., 2019; Harris and Rubinsztein, 2011; Menzies et al., 2017; Rubinsztein et al., 2015).”
Naudin, M., Mondon, K., El-Hage, W., Perriot, E., Boudjarane, M., Desmidt, T., Lorette, A., Belzung, C., Hommet, C., & Atanasova, B. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.03.021 · Cited by 19 · cited 2× · see citing works
“In advanced AD, patients often complain of anhedonia, or the inability to sense or experience pleasure (Naudin et al., 2015; Reichman and Coyne, 1995), which can be analyzed in mice using a sucrose preference test (SPT) (Briones et al., 2012; Liu et al., 2018).”
Neuronal migration and its disorders affecting the CA3 region
Belvindrah, R., Nosten-Bertrand, M., & Francis, F. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00063 · Cited by 18 · cited 1× · see citing works
“This region has been implicated as one of the first sites of neuronal dysfunction and neuronal death in AD (Belvindrah et al., 2014; Padurariu et al., 2012; Zhang et al., 2013).”
Flagged first, then by citations
1 of the 90 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204 · see citing works
“Microglia appear to clear Aβ through a process termed LC3-associated endocytosis (LANDO) that also recycles Aβ receptors (CD36, TREM2, TLR4) back to the cell surface; if this is genetically deleted in 5xFAD mice, there is increased Aβ accumulation, microgliosis with release of proinflammatory cytokines, tau hyperphosp…”
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,622 · see citing works
Self-citationMicroglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585 · see citing works
Self-citationAutophagy and autophagy-related pathways in cancer
Debnath, J., Gammoh, N., & Ryan, K. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00585-z · Cited by 1,443 · see citing works
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Yamamoto, K., Venida, A., Yano, J., Biancur, D. E., Kakiuchi, M., Gupta, S., Sohn, A. S. W., Mukhopadhyay, S., Lin, E. Y., Parker, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2229-5 · Cited by 1,240 · see citing works
Spangenberg, E., Severson, P. L., Hohsfield, L. A., Crapser, J., Zhang, J., Burton, E. A., Zhang, Y., Spevak, W., Lin, J., Phan, N. Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11674-z · Cited by 939 · see citing works
The clearance of dead cells by efferocytosis
Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0232-1 · Cited by 893 · see citing works
Self-citationAutophagy in inflammation, infection, and immunometabolism
Deretic, V. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.018 · Cited by 862 · see citing works
Leidal, A. M., Huang, H. H., Marsh, T., Solvik, T. A., Zhang, D., Ye, J., Kai, F., Goldsmith, J., Liu, J. Y., Huang, Y.-H., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-019-0450-y · Cited by 480 · see citing works
The different autophagy degradation pathways and neurodegeneration
Fleming, A., Bourdenx, M., Fujimaki, M., Karabiyik, C., Krause, G. J., Lopez, A., Martín‐Segura, A., Puri, C., Scrivo, A., Skidmore, J., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.01.017 · Cited by 485 · see citing works
The emerging mechanisms and functions of microautophagy
Wang, L., Klionsky, D. J., & Shen, H. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00529-z · Cited by 473 · see citing works
Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases
Nixon, R. A., & Rubinsztein, D. C. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00757-5 · Cited by 435 · see citing works
Autophagy in tumour immunity and therapy
Xia, H., Green, D. R., & Zou, W. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00344-2 · Cited by 411 · see citing works
Self-citationAutophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives
Zhang, Z., Yang, X., Song, Y., & Tu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101464 · Cited by 378 · see citing works
Autophagy and disease: unanswered questions
Yang, Y., & Klionsky, D. J. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-019-0480-9 · Cited by 369 · see citing works
Cai, Y., Liu, J., Wang, B., Sun, M., & Yang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856376 · Cited by 351 · see citing works
Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology
Settembre, C., & Perera, R. M. (2023) · Nature reviews. Molecular cell biology · doi:10.1038/s41580-023-00676-x · Cited by 269 · see citing works
Autophagy, aging, and age-related neurodegeneration
Palmer, J. E., Wilson, N., Son, S. M., Obrocki, P., Wróbel, L., Rob, M., Takla, M., Korolchuk, V. I., & Rubinsztein, D. C. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.015 · Cited by 255 · see citing works
Nakamura, S., Shigeyama, S., Minami, S., Shima, T., Akayama, S., Matsuda, T., Esposito, A., Napolitano, G., Kuma, A., Namba-Hamano, T., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00583-9 · Cited by 235 · see citing works
Dewanjee, S., Chakraborty, P., Bhattacharya, H., Chacko, L., Singh, B., Chaudhary, A., Javvaji, K., Pradhan, S. R., Vallamkondu, J., Dey, A., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.032 · Cited by 235 · see citing works
Targeting autophagy in disease: established and new strategies
Koçak, M., Erdi, S. E., Jorba, G., Maestro, I., Farrés, J., Kirkin, V., Martı́nez, A., & Pleß, O. (2021) · Autophagy · doi:10.1080/15548627.2021.1936359 · Cited by 229 · see citing works
Non-canonical autophagy drives alternative ATG8 conjugation to phosphatidylserine
Durgan, J., Lystad, A. H., Sloan, K., Carlsson, S. R., Wilson, M. I., Marcassa, E., Ulferts, R., Webster, J. A., Lopez‐Clavijo, A. F., Wakelam, M. J. O., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.020 · Cited by 216 · see citing works
Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis
Wen, J.-H., Li, D.-Y., Liang, S., Yang, C., Tang, J., & Liu, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.946832 · Cited by 218 · see citing works
Beyond autophagy: LC3-associated phagocytosis and endocytosis
Peña-Martinez, C., Rickman, A. D., & Heckmann, B. L. (2022) · Science Advances · doi:10.1126/sciadv.abn1702 · Cited by 212 · see citing works
Self-citationCXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathology
Su, W., Saravia, J., Risch, I., Rankin, S. L., Guy, C. S., Chapman, N. M., Shi, H., Sun, Y., Anil, K. C., Li, W., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01604-z · Cited by 216 · see citing works
Self-citationActivation and targeting of ATG8 protein lipidation
Martens, S., & Fracchiolla, D. (2020) · Cell Discovery · doi:10.1038/s41421-020-0155-1 · Cited by 206 · see citing works
Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence
Choi, I., Wang, M., Yoo, S., Xu, P., Seegobin, S. P., Li, X., Han, X., Wang, Q., Peng, J., Zhang, B., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01158-0 · Cited by 202 · see citing works
V-ATPase is a universal regulator of LC3-associated phagocytosis and non-canonical autophagy
Hooper, K. M., Jacquin, É., Li, T., Goodwin, J. M., Brumell, J. H., Durgan, J., & Florey, O. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202105112 · Cited by 188 · see citing works
Durgan, J., & Florey, O. (2022) · Science Advances · doi:10.1126/sciadv.abo1274 · Cited by 176 · see citing works
Autophagy and endocytosis – interconnections and interdependencies
Birgisdottir, Å. B., & Johansen, T. (2020) · Journal of Cell Science · doi:10.1242/jcs.228114 · Cited by 170 · see citing works
Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy
Chen, M., Hong, C., Yue, T., Li, H., Duan, R., Hu, W., Cao, J., Wang, Z., Chen, C., Hu, X., et al. (2020) · Theranostics · doi:10.7150/thno.47408 · Cited by 166 · see citing works
Xu, Y., Propson, N. E., Du, S., Xiong, W., & Zheng, H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023418118 · Cited by 171 · see citing works
Lysosomes in senescence and aging
Tan, J. X., & Finkel, T. (2023) · EMBO Reports · doi:10.15252/embr.202357265 · Cited by 160 · see citing works
Microglial autophagy–associated phagocytosis is essential for recovery from neuroinflammation
Berglund, R., Guerreiro-Cacais, A. O., Adzemovic, M. Z., Zeitelhofer, M., Lund, H., Ewing, E., Ruhrmann, S., Nutma, E., Parsa, R., Thessen-Hedreul, M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb5077 · Cited by 149 · see citing works
Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158 · see citing works
Lee, J., Kim, D. E., Griffin, P. Y., Sheehan, P. W., Kim, D., Musiek, E. S., & Yoon, S. (2019) · Aging Cell · doi:10.1111/acel.13078 · Cited by 156 · see citing works
Yuan, J., Liu, H., Zhang, H., Wang, T., Zheng, Q. Y., & Li, Z. (2022) · Advanced Materials · doi:10.1002/adma.202108435 · Cited by 155 · see citing works
Chen, Y., Chen, Y., Liang, Y., Chen, H.-D., Ji, X., & Huang, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109670 · Cited by 145 · see citing works
Macroautophagy in CNS health and disease
Griffey, C. J., & Yamamoto, A. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00588-3 · Cited by 144 · see citing works
Goodwin, J. M., Walkup, W. G., Hooper, K. M., Li, T., Kishi‐Itakura, C., Ng, A., Lehmberg, T. Z., Jha, A., Kommineni, S., Fletcher, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj2485 · Cited by 130 · see citing works
Iyaswamy, A., Thakur, A., Guan, X.-J., Krishnamoorthi, S., Fung, T. Y., Lu, K., Gaurav, I., Yang, Z., Su, C.-F., Lau, K.-F., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01657-4 · Cited by 134 · see citing works
Beyond Autophagy: The Expanding Roles of ATG8 Proteins
Nieto-Torres, J. L., Leidal, A. M., Debnath, J., & Hansen, M. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.01.004 · Cited by 128 · see citing works
Hu, X., Li, Z., Lin, R., Shan, J.-Q., Yu, Q., Wang, R., Liao, L., Yan, W., Zhen, W., Shang, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634690 · Cited by 127 · see citing works
Autophagy in health and disease: From molecular mechanisms to therapeutic target
Lu, G. X., Wang, Y., Shi, Y. P., Zhang, Z., Huang, C., He, W., Wang, C., & Shen, H. (2022) · MedComm · doi:10.1002/mco2.150 · Cited by 127 · see citing works
Inflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 134 · see citing works
Noncanonical function of an autophagy protein prevents spontaneous Alzheimer’s disease
Heckmann, B. L., Teubner, B. J. W., Boada-Romero, E., Tummers, B., Guy, C., Fitzgerald, P., Mayer, U., Carding, S., Zakharenko, S. S., Wileman, T., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb9036 · Cited by 114 · see citing works
Self-citationMicrobiota modulation as preventative and therapeutic approach in Alzheimer’s disease
Bonfili, L., Cecarini, V., Gogoi, O., Gong, C., Cuccioloni, M., Angeletti, M., Rossi, G., & Eleuteri, A. M. (2020) · FEBS Journal · doi:10.1111/febs.15571 · Cited by 118 · see citing works
Tan, H. W. S., Lu, G. X., Dong, H., Cho, Y.-L., Natalia, A., Wang, L., Chan, C., Kappei, D., Taneja, R., Ling, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31213-7 · Cited by 112 · see citing works
Polystyrene microplastics induce an immunometabolic active state in macrophages
Merkley, S. D., Moss, H. C., Goodfellow, S. M., Ling, C. L., Meyer-Hagen, J. L., Weaver, J. M. R., Campen, M. J., & Castillo, E. F. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09616-x · Cited by 110 · see citing works
Autophagy promotes mammalian survival by suppressing oxidative stress and p53
Yang, Y., Karsli-Uzunbas, G., Poillet-Perez, L., Sawant, A., Hu, Z. S., Zhao, Y., Moore, D., Hu, W., & White, E. (2020) · Genes & Development · doi:10.1101/gad.335570.119 · Cited by 100 · see citing works
FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation
Cai, W., Hu, M., Li, C., Wu, R., Lu, D., Xie, C., Zhang, W., Li, T., Shen, S., Huang, H., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2116833 · Cited by 106 · see citing works
Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin
Wijshake, T., Zou, Z., Chen, B., Zhong, L., Xiao, G., Xie, Y., Doench, J. G., Bennett, L. B., & Levine, B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020478118 · Cited by 104 · see citing works
The Multiple Roles of Autophagy in Neural Function and Diseases
Li, Y., Qin, Z., & Sheng, R. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01120-y · Cited by 106 · see citing works
Xu, F., Mu, J., Teng, Y., Zhang, X., Sundaram, K., Sriwastva, M. K., Kumar, A., Lei, C., Zhang, L., Liu, Q. M., et al. (2021) · Small · doi:10.1002/smll.202105385 · Cited by 103 · see citing works
Lysosome damage triggers direct ATG8 conjugation and ATG2 engagement via non-canonical autophagy
Cross, J., Durgan, J., McEwan, D. G., Tayler, M., Ryan, K. M., & Florey, O. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202303078 · Cited by 103 · see citing works
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102 · see citing works
Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes
Kumar, S. G., Javed, R., Mudd, M. H., Pallikkuth, S., Lidke, K. A., Jain, A., Tangavelou, K., Gudmundsson, S. R., Ye, C., Rusten, T. E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.10.017 · Cited by 98 · see citing works
A non-canonical role of ATG8 in Golgi recovery from heat stress in plants
Zhou, J. M., Ma, J., Yang, C., Zhu, X., Li, J., Zheng, X., Li, X., Chen, S., Feng, L., Wang, P., et al. (2023) · Nature Plants · doi:10.1038/s41477-023-01398-w · Cited by 97 · see citing works
Emerging roles for the autophagy machinery in extracellular vesicle biogenesis and secretion
Leidal, A. M., & Debnath, J. (2021) · FASEB BioAdvances · doi:10.1096/fba.2020-00138 · Cited by 90 · see citing works
Alternative systems for misfolded protein clearance: life beyond the proteasome
Johnston, H. E., & Samant, R. S. (2020) · FEBS Journal · doi:10.1111/febs.15617 · Cited by 89 · see citing works
Autophagy in Neuronal Development and Plasticity
Fleming, A., & Rubinsztein, D. C. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.07.003 · Cited by 93 · see citing works
Autophagy, Cellular Aging and Age-related Human Diseases
Cheon, S. Y., Kim, H. J., Rubinsztein, D. C., & Lee, J. E. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.6.643 · Cited by 92 · see citing works
Exploring the bi‐directional relationship between autophagy and Alzheimer’s disease
Kuang, H., Tan, C., Tian, H., Liu, L., Yang, M.-W., Hong, F., & Yang, S. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13216 · Cited by 92 · see citing works
Self-citationGao, J.-M., Zhang, X., Shu, G., Chen, N., Zhang, J., Xu, F., Li, F., Liu, Y., Wei, Y., He, Y., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00888-5 · Cited by 95 · see citing works
Macroautophagy and aging: The impact of cellular recycling on health and longevity
Nieto-Torres, J. L., & Hansen, M. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101020 · Cited by 91 · see citing works
Yang, T., Zhang, S., Yuan, H., Wang, Y., Cai, L., Chen, H., Wang, X., Song, D., Wang, X., Guo, Z., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202213337 · Cited by 90 · see citing works
Mechanisms and Pathophysiological Roles of the ATG8 Conjugation Machinery
Lystad, A. H., & Simonsen, A. (2019) · Cells · doi:10.3390/cells8090973 · Cited by 89 · see citing works
Selective Lysosome Membrane Turnover Is Induced by Nutrient Starvation
Lee, C., Lamech, L. T., Johns, E., & Overholtzer, M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.08.008 · Cited by 88 · see citing works
Xu, Y., Li, Y., Wang, C., Han, T., Liu, H., Sun, L., Hong, J., Hashimoto, M., & Wei, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02723-y · Cited by 88 · see citing works
Lysosomal quality control: molecular mechanisms and therapeutic implications
Yang, H., & Tan, J. X. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.01.001 · Cited by 84 · see citing works
Noteworthy perspectives on microglia in neuropsychiatric disorders
Zhu, H., Guan, A., Liu, J., Li, P., Zhang, Z., & Wang, S. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02901-y · Cited by 90 · see citing works
Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework
Mentis, A. A., Dardiotis, E., & Chrousos, G. P. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0731-7 · Cited by 82 · see citing works
Zheng, Q., Li, G., Wang, S., Zhou, Y., Liu, K., Gao, Y., Zhou, Y., Zheng, L., Zhu, L., Deng, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe1340 · Cited by 85 · see citing works
The beneficial role of autophagy in multiple sclerosis: Yes or No?
Al-Kuraishy, H. M., Jabir, M. S., Al-Gareeb, A. I., Saad, . M., Batiha, G. E., & Klionsky, D. J. (2023) · Autophagy · doi:10.1080/15548627.2023.2259281 · Cited by 86 · see citing works
CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation
Keller, C. W., Kotur, M. B., Mundt, S., Dokalis, N., Ligeon, L., Shah, A. M., Prinz, M., Becher, B., Münz, C., & Lünemann, J. D. (2020) · Autophagy · doi:10.1080/15548627.2020.1756678 · Cited by 85 · see citing works
Inflammasome assembly in neurodegenerative diseases
Singh, J., Habean, M. L., & Panicker, N. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.009 · Cited by 83 · see citing works
Autophagy-related protein PIK3C3/VPS34 controls T cell metabolism and function
Yang, G., Song, W., Postoak, J. L., Chen, J., Martinez, J., Zhang, J., Wu, L., & Kaer, L. V. (2020) · Autophagy · doi:10.1080/15548627.2020.1752979 · Cited by 79 · see citing works
Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Dai, J., Lah, J. J., Johnson, E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107807 · Cited by 78 · see citing works
TECPR1 conjugates LC3 to damaged endomembranes upon detection of sphingomyelin exposure
Boyle, K. B., Ellison, C. J., Elliott, P. R., Schuschnig, M., Grimes, K., Dionne, M., Sasakawa, C., Munro, S., Martens, S., & Randow, F. (2023) · The EMBO Journal · doi:10.15252/embj.2022113012 · Cited by 78 · see citing works
Identification of conserved proteomic networks in neurodegenerative dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Lah, J. J., Johnson, E. E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2019) · doi:10.1101/825802 · Cited by 78 · see citing works
He, Z., Yang, Y., Xing, Z., Zuo, Z., Wang, R., Gu, H., Qi, F., & Yao, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2644-4 · Cited by 77 · see citing works
A guide to membrane atg8ylation and autophagy with reflections on immunity
Deretic, V. P., & Lazarou, M. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202203083 · Cited by 78 · see citing works
Immune Activation in Alzheimer Disease
Mary, A., Mancuso, R., & Heneka, M. T. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-035222 · Cited by 79 · see citing works
Autophagy in metabolism and quality control: opposing, complementary or interlinked functions?
Deretic, V. P., & Kroemer, G. (2021) · Autophagy · doi:10.1080/15548627.2021.1933742 · Cited by 76 · see citing works
Autophagy in cancer cell remodeling and quality control
Hernandez, G. A., & Perera, R. M. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.023 · Cited by 73 · see citing works
Li, T., Su, X., Lu, P., Kang, X., Hu, M., Li, C., Wang, S., Lu, D., Shen, S., Huang, H., et al. (2023) · Advanced Science · doi:10.1002/advs.202206432 · Cited by 74 · see citing works
Wang, Y., Sharma, P., Jefferson, M. A., Zhang, W., Bone, B., Kipar, A., Bitto, D., Coombes, J. L., Pearson, T., Man, A., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105543 · Cited by 72 · see citing works
Regulation of Innate Immune Responses by Autophagy: A Goldmine for Viruses
Pradel, B., Robert-Hebmann, V., & Espert, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.578038 · Cited by 69 · see citing works
Circadian clock protein BMAL1 broadly influences autophagy and endolysosomal function in astrocytes
McKee, C. A., Polino, A. J., King, M. W., & Musiek, E. S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220551120 · Cited by 70 · see citing works
Mallucci, G. R., Klenerman, D., & Rubinsztein, D. C. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-040320-120625 · Cited by 62 · see citing works
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67 · see citing works
Gong, Y., Huang, A., Guo, X., Zhi, J., Chen, X., Zhu, X., Xia, Y., Liu, J., Xu, Y., & Qin, X. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129345 · Cited by 63 · see citing works
LC3-associated endocytosis and the functions of Rubicon and ATG16L1
Magné, J., & Green, D. R. (2022) · Science Advances · doi:10.1126/sciadv.abo5600 · Cited by 63 · see citing works
Self-citationAtg8ylation as a general membrane stress and remodeling response
Kumar, S. G., Jia, J., & Deretic, V. P. (2021) · Cell Stress · doi:10.15698/cst2021.09.255 · Cited by 62 · see citing works
Rahman, M. A., Rahman, M. S., Rahman, M. H., Rasheduzzaman, M., Mamun-Or-Rashid, A. N. M., Uddin, M. J., Rahman, M. R., Hwang, H., Pang, M., & Rhim, H. (2020) · Biomedicines · doi:10.3390/biomedicines9010005 · Cited by 62 · see citing works
Estfanous, S. Z. K., Daily, K. P., Eltobgy, M. M., Deems, N. P., Anne, M. N. K., Krause, K., Badr, A., Hamilton, K., Carafice, C., Hegazi, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705581 · Cited by 63 · see citing works
Meng, J., Han, L., Zheng, N., Wang, T., Xu, H., Jiang, Y., Wang, Z., Liu, Z., Zheng, Q., Zhang, X., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1644-21.2022 · Cited by 65 · see citing works
Targeting Autophagy to Treat Cancer: Challenges and Opportunities
Lim, J., & Murthy, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.590344 · Cited by 59 · see citing works
Liu, Z.-Q., Deng, Q.-Q., Qin, G., Yang, J., Zhang, H., Ren, J.-S., & Qu, X.-G. (2023) · Chem · doi:10.1016/j.chempr.2023.06.003 · Cited by 54 · see citing works
- Authors
- Heckmann, B. L., Teubner, B. J. W., Tummers, B., Boada-Romero, E., Harris, L., Yang, M., Guy, C. S., Zakharenko, S. S., & Green, D. R.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Green, Douglas R.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 178
- Issue
- 3
- Pages
- 536-551.e14
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6689199
- OpenAlex
- W2953948138
- Semantic Scholar
- f14bdb656ef7b729cf199d36d42394767974c4eb
- Cited by
- 503
- References
- 90
- Citations by year
- 2026: 42 · 2025: 77 · 2024: 73 · 2023: 71 · 2022: 82 · 2021: 76 · 2020: 65 · 2019: 16 · 2018: 1
- FWCI
- 40.96
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Lupus Research Alliance
- American Lebanese Syrian Associated Charities
- National Institutes of Health (AI138492, AI40646, CA231423, CA231620)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Lando, Alzheimer's disease, amyloid-beta clearance, microglia, autophagy, neuroinflammation, reactive microgliosis, tau hyperphosphorylation, neurodegeneration, memory impairment, inflammatory cytokines
- MeSH terms
- RAW 264.7 Cells, Autophagy-Related Proteins, Autophagy-Related Protein 5, Alzheimer Disease, Animals, Disease Models, Animal, Endocytosis, Hippocampus, Membrane Glycoproteins, Mice, Transgenic, Microtubule-Associated Proteins, Receptors, Immunologic, Cytokines, Amyloid beta-Peptides, Microglia, CD36 Antigens, Intracellular Signaling Peptides and Proteins, Toll-Like Receptor 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review